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Relaxation-Compensated Amide Chemical Exchange Saturation Trans-
fer MRI of the Human Breast:
Early detection of breast cancer is associated with reduced mortality. As an
adjunct to X-ray mammography, magnetic resonance imaging (MRI) is used for
clarification of suspicious lesions. Beyond conventionally applied MRI modalities,
chemical exchange saturation transfer (CEST) MRI has the potential to provide
insights on biochemical tumor environment. Particularly the amide CEST signal
originating from proteins has been shown to correlate with parameters of high
clinical relevance. However, in the breast, the amide CEST signal is compromised
by fat-signal-induced artifacts. Moreover, a profound interpretation requires an
isolation of superimposing CEST signals and correction for water relaxation prop-
erties.
The aim of this thesis was to account for these factors and to enable relaxation-
compensated amide CEST MRI of the human breast. A general theoretical
description allowed the correction for fat-signal-induced artifacts by a novel post-
processing algorithm. In addition, established methods for mapping of water
relaxation properties were enhanced for a robust performance in the presence of
fat. This enabled – for the first time – examinations of breast cancer patients
using relaxation-compensated amide CEST MRI. In three patients a significant
increase of the amide CEST contrast was observed compared to healthy volunteers.
Hormonal-induced fluctuations in the amide CEST contrast were shown to be
negligible.
Relaxationskorrigierte Amid-CEST-MRT der menschlichen Brust:
Frühzeitige Erkennung von Brustkrebs wird mit einer verringerten Mortalität in
Verbindung gebracht. Zusätzlich zur Röntgenmammographie kann die Magnet-
resonanztomographie (MRT) zur Abklärung von verdächtigen Läsionen zu Rate
gezogen werden. Neben den konventionellen MRT-Modalitäten bietet die auf
chemischen Austausch (CEST) basierende MRT die Möglichkeit, Einblick in bio-
chemische Eigenschaften der Tumore zu erhalten. Insbesondere korreliert das
CEST-Signal von Amid-Protonen aus Proteinen mit klinisch wertvollen Gewebs-
parametern. Die Anwendung in der Brust ist jedoch von fettsignalinduzierten
Störeinflüssen beeinträchtigt. Des Weiteren bedarf eine fundierte Dateninterpreta-
tion einer Isolierung von sich überlagernden CEST-Signalen sowie einer Korrektur
für die Relaxationseigenschaften des Wassers.
Das Ziel dieser Arbeit war die Berücksichtigung dieser Störeinflüsse, um eine
relaxationskorrigierte Amid-CEST-MR-Aufnahme der weiblichen Brust zu er-
möglichen. Eine allgemeine Herleitung ermöglichte die Korrektur der fettsignalin-
duzierten Artefakte mittels eines eigen entwickelten Postprocessing-Algorithmus.
Bereits etablierte Methoden zur Bestimmung der Wasserrelaxationseigenschaften
wurden erweitert, um deren robuste Funktionsweise trotz Anwesenheit des Fetts
in der Brust sicherzustellen. In Summe ermöglichte dies erstmalig die Unter-
suchung von Brustkrebspatientinnen mittels relaxationskorrigierter Amid-CEST-
MR-Mammographie. Verglichen mit gesunden Probandinnen wies der Amid-
Kontrast eine deutliche Erhöhung bei drei untersuchten Patientinnen auf. Es
konnte gezeigt werden, dass hormonell bedingte Schwankungen des Amid-Kontrasts
minimal und vernachlässigbar sind.
V
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1 | Introduction
Breast cancer is the most common cancer in women, with around 70,000 incidences each year in
Germany [1]. Screening X-ray mammography has been associated with a reduced mortality due
to early detection [2], but is not suitable for women with an increased cancer risk or extremely
dense breasts [3]. Mammography by means of magnetic resonance imaging (MRI) presents an
adjunct screening modality [3]. The soft tissue contrast of conventional MRI is insufficient for
lesion detection and requires uptake dynamics by means of gadolinium-based contrast agents to
be of diagnostic value. Dynamic-contrast-enhanced (DCE) MRI presents the current standard
alternative to X-ray mammography and can support clarification of suspicious lesions [3, 4].
However, DCE MRI of the breast provides only modest specificity in clinical practice, despite
the additional information associated with tissue perfusion properties [5]. Recently, completely
non-invasive alternatives for breast MRI gained popularity. One of those is diffusion weighted
imaging (DWI) which is increasingly being incorporated into clinical routine despite certain
limitations [5]. DWI supports tumor detection in the breast by detecting the biophysical
characteristics of tissue water and thus, yields information on the cellular environment [5–7].
Another alternative modality that probes the biochemical environment is given by chemical
exchange saturation transfer (CEST) MRI [8]. CEST MRI indirectly detects protons loosely
bound in endogenous low concentrated biomolecules undergoing chemical exchange with water.
In particular, CEST signals originating from amide resonances of the peptide bonds in the
backbone of mobile proteins are related to protein concentration and conformation, which are
known to be altered in tumors [9, 10]. Additionally, amide CEST MRI has been shown to
correlate with biomarkers in human brain tumors [11] and can be associated with survival
in high-grade glioma patients [12]. For these reasons, the application of CEST MRI as a
diagnostic tool for mamma carcinoma patients is promising.
Conventional CEST MRI of the human breast was first performed by Schmitt et al. [13]. Since
then, several studies correlated the amide CEST signal to an early treatment response during
neoadjuvant chemotherapy [14] and found correlations to tumor aggressiveness [15]. However,
these studies did not account for water relaxation properties (i.e. T1 and T2), which were
shown to influence observed CEST effects [16]. Moreover, multiple CEST signals were shown
to superimpose, thus requiring the isolation and a compensation for relaxation times [17]
to enable a profound interpretation. Relaxation-compensated and isolated CEST contrasts
are dependent on the saturation amplitude in the CEST experiment and are for that reason
affected by field inhomogeneities present in breast MRI [18, 19]. Foremost, CEST MRI of the
breast is compromised by fat-signal-induced artifacts [15, 20]. These fat artifacts depend on
imaging parameters, in particular the echo time (TE).
The aim of this thesis was to account for these challenges to enable relaxation-compensated
amide CEST MRI of the human breast. A general theoretical description was derived explaining
the interplay of water and fat signals during a CEST experiment for arbitrary TE, and thus, the
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origin of these artifacts. This allowed the correction of CEST data for fat signals by a novel nor-
malization algorithm based on data postprocessing. Established fitting routines were adapted
to isolate amide CEST signals and to compensate for T2 relaxation [16]. A self-developed fat
saturation presented an improvement for field and T1 mapping and allowed for a robust quan-
tification. Together, this enabled — for the first time — examinations of mamma carcinoma
patients using relaxation-compensated amide CEST MRI. The analysis of three patients of
an ongoing clinical pilot study is included in this thesis. A significant increase of the amide
CEST contrast was observed compared to healthy volunteers. Potential hormonal-induced
changes of the contrast during menstrual cycle were investigated in healthy premenopausal
women. The observed fluctuations were minimal and, with respect to tumor imaging, negligible.
The origin of nuclear magnetic resonance and the basics of MRI are explained in Chapter 2.
Furthermore, information about the anatomy and physiology of the human female breast is
provided. Chapter 3 introduces the fundamentals of chemical exchange from a physical point
of view and describes the CEST experiment. In Chapter 4, a general formulation of water
and fat signals during a CEST experiment is derived. Also, the novel normalization is defined
and challenges of relaxation-compensated CEST MRI of the breast are outlined. Methods and
methodological developments are described in Chapter 5. The advanced in vivo examination
protocol as well as the post-processing workflow are provided. The obtained results (Ch. 6)
are discussed in Chapter 7. Finally, a summary is given in Chapter 8.
2
2 | Physical and anatomical basics
The fundamental theory of nuclear magnetic resonance (NMR) is briefly described in the
following sections as well as some principles used in magnetic resonance imaging (MRI).
For more details, the reader is referred to standard literature of NMR physics, for instance
textbooks [21], [22] and [23]. Subsequently, a brief overview on the anatomy of the human
breast is presented.
2.1 Nuclear spins in a magnetic field
Every atomic nucleus consists of protons and neutrons. Protons and neutrons are fermions
with a spin of one half. The nucleus of hydrogen consists only of one proton (1H). Its nuclear
spin ~I is therefore 1/2, obeying the algebra of quantum mechanical angular momentum. The
commutator relations of the nuclear spin operator ~ˆI = (Iˆx, Iˆy, Iˆz) are:
[Iˆk, Iˆl] = i~ klmIˆm (2.1)
[~ˆI 2, Iˆk] = 0 (2.2)
with the Levi-Civita symbol klm and k, l,m ∈ {x, y, z}. The eigenstates of the commuting
operator ~ˆI 2 and Iˆz are the angular momentum quantum number I and the magnetic quantum
number m = (−I,−I + 1, ..., I − 1, I) :
~ˆI 2 |I,m〉 = ~2I(I + 1) |I,m〉 (2.3)
Iˆz |I,m〉 = ~m |I,m〉 (2.4)
with ∆m = 1. A magnetic moment ~ˆµ is associated with the nuclear spin:
~ˆµ = γ~ˆI (2.5)
where γ is nucleus specific gyromagnetic ratio. For hydrogen, the gyromagnetic ratio was
experimentally determined to γ = 2.675 · 108 rads · T , γ2pi = 42.576 MHzT . If an external magnetic
field ~B = (0, 0, B0) is applied, the magnetic moment can be described by the Hamiltonian:
Hˆ = −~ˆµ · ~B = −µˆz ·B0 = −γIˆz ·B0 (2.6)
The Hamiltonian and the angular momentum are linear, hence their commutator relations
are:
[
~ˆI 2, Hˆ
]
= 0 and
[
Iˆz, Hˆ
]
= 0. Therefore, the eigenstates |I,m〉 of the nuclear spin are
also eigenstates of Hˆ. One can formulate the time-independent Schrödinger equation for static
magnetic fields:
Hˆ |I,m〉 = Em |I,m〉 = −γm~B0 |I,m〉 (2.7)
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This leads to the Zeeman effect [24]: a discrete splitting into 2I + 1 equidistant energy levels
due to the different magnetic quantum numbers m. The transition between these energy levels
is accompanied by the emission or absorption of a photon of discrete energy. For the proton of
spin 1/2, the energy difference of the two possible eigenstates |α〉 =
∣∣∣12 ,−12〉 and |β〉 = ∣∣∣12 ,+12〉
is (Fig. 2.1):
∆E = Eα − Eβ = ~γB0 = ~ω0 (2.8)
with ω0 = γB0 being the Larmor frequency. In case of a static magnetic field of B0 = 7 T, the
Larmor frequency is ω0/(2pi) ≈ 298 MHz for protons. In case of irradiation with time-varying
magnetic fields of the radial frequency ω0, the resonance causes a depopulation of |β〉 and a
population gain of |α〉.
Figure 2.1: Zeeman splitting of energy lev-
els for a nucleus of spin quantum number
I = 1/2 as a function of B0. The energy dif-
ference between the two states |α〉 and |β〉 is
∆E = γ~ B0.
B0
E
|β〉
|α〉
∆E = γ~B0
2.2 Macroscopic Magnetization
In order to perform an NMR experiment, one has to transfer the description of singular spins
to a spin ensemble. In case of a macroscopic volume with a fixed number of nuclei that are in
thermal equilibrium, one can describe the population probability p(Em) by the Boltzmann
statistic:
p(Em) =
1
Z
e
− Em
kBT (2.9)
with the canonical number of states Z = ∑Im=−I e− EmkBT , the Boltzmann constant kB and T
being the equilibrium temperature. As shown in the previous Section 2.1, the proton with spin
I = 1/2 only has two energy states |α〉 and |β〉. For such a two-level system, the expectation
value of the z-component of the magnetic moment is given by:
〈µˆz〉 = γ〈Iˆz〉 = γ
(
p− 12 〈α|Iˆz|α〉+ p+ 12 〈β|Iˆz|β〉
)
(2.10)
= 12γ~ · (p+ 12 − p− 12 ) =
1
2γ~ · P (2.11)
where the difference between the two probabilities P , is also known as the polarization and
represents the normalized difference in population:
P = p+ 12 − p− 12 =
∆N
N
(2.12)
By inserting the energy eigenvalues (Em = −γ~mB0, Eq. 2.7) into the population probability
(Eq. 2.9), the polarization becomes:
P = e
γ~B0
2kBT − e−
γ~B0
2kBT
e
γ~B0
2kBT + e−
γ~B0
2kBT
= tanh
(
γ~B0
2kBT
)
(2.13)
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Since γ~B0  kBT at room temperature, a Taylor expansion of the polarization yields
P ≈ γ~B02kBT . With kB = 1.381 · 10−23 JK and ~ = 1.055 · 10−34 J · s, the polarization in an
ensemble of protons is P ≈ 2.4 · 10−5 for room temperature and B0 = 7 T. The macroscopic
magnetization of the spin ensemble is yielded by summing up all N magnetic moments in the
volume V :
~M = N
V
〈~ˆµ〉 = 12γ~
N
V
~P ≈ 14
N
V
γ2~2
kBT
~B (2.14)
A detectable magnetization is only present at room temperature due to the large abundance
of protons per volume (for water ≈ 6.6 · 1019 1mm3 ).
2.2.1 Time evolution of the magnetization
The time-dependent Schrödinger equation can be used to describe a spin in a time-dependent
magnetic field:
i~
∂
∂t
|I,m〉 = Hˆ(t)|I,m〉 (2.15)
with Hˆ(t) = −~ˆµ · ~B(t) being the time-dependent Hamiltonian. The Ehrenfest theorem [25] can
be applied to calculate the time dependence of the expectation value of the magnetic moment
~ˆµ:
d
dt
〈~ˆµ〉 = i
~
〈
[
Hˆ, ~ˆµ
]
〉+ 〈∂~ˆµ
∂t
〉 (2.16)
Application of the commutator relations from Equation 2.2 gives:
d
dt
〈~ˆµ〉 = 〈~ˆµ〉 × γ ~B(t) (2.17)
A transition from a quantum mechanical description of 〈~ˆµ〉 to a classical description of the
macroscopic magnetization ~M is justified by the correspondence principle [26] and the large
abundance of protons per volume. The time-dependent expectation value of ~M becomes:
d
dt
~M = ~M(t)× γ ~B(t) (2.18)
Without loss of generality, the static magnetic field ~B0 = (0, 0, B0) in z-direction is superposed
by an oscillating radio frequency (RF) field ~B1 in the xy-plane at frequency ωRF . This leads to
the time dependent magnetic field:
~B(t) = ~B0 + ~B1(t) =
 00
B0
+B1
cos(ωRFt)sin(ωRFt)
0
 (2.19)
A description of ddt ~M can be simplified by a transformation into a rotating frame of reference
(x′, y′, z′ = z). If this reference frame rotates at ωRF , both ~B0 and ~B1 are static. Furthermore,
~B1 is aligned in x’-direction, yielding:
d
dt
~M ′(t) = ~M ′(t)× γ ~Beff (2.20)
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with the effective magnetic field ~Beff :
~Beff =
 B10
B0 − ωRFγ
 (2.21)
The z-component of ~Beff vanishes, if the system is in resonance and ωRF = ω0 = γB0. Then,
the external magnetic field only affects the magnetization ~M in x’-direction, which performs a
precession in the y’-z-plane with the frequency ω1 = γB1. From the laboratory perspective,
the ~B1(t) field induces a spiral flip of ~M . The flip angle α describing the angle between the
magnetization and the z-axis depends on the duration tp of irradiation:
α =
∫ tp
0
ω1(t)dt =
∫ tp
0
γB1(t)dt (2.22)
If the RF irradiation is switched off, the magnetization ~M precesses in the xy-plane with the
Larmor frequency ω0 and returns back to the thermal equilibrium.
2.2.2 Bloch equations
The prepared magnetization represents an excited state. Over time, the excitation decays
due to the interactions of the nuclei with their environment, described by the spin-lattice
relaxation time T1. Additionally, the spin system gradually looses its phase coherence, which
is characterized by the spin-spin relaxation time T2. The equation 2.20 was expanded by Felix
Bloch [27] with the following, phenomenological relaxation terms:
d
dt
Mx′ = γ( ~M × ~B)x′ − Mx
′
T2
(2.23)
d
dt
My′ = γ( ~M × ~B)y′ − My
′
T2
(2.24)
d
dt
Mz = γ( ~M × ~B)z − Mz −M0
T1
(2.25)
Next to the intrinsic T2 relaxation, the spins are additionally dephased by local field inhomo-
geneities of the static field B0. The apparent relaxation T ∗2 is:
1
T ∗2
= 1
T2
+ 1
T
′
2
(2.26)
with the term T ′2 = γ∆B0 describing the dephasing due to field inhomogeneities ∆B0.
2.2.3 The NMR signal
By defining the longitudinal part of the Bloch-equations (2.23-2.25) as M‖ = Mz and the
transverse component M⊥ = Mx + iMy, one can formulate the relaxation processes of the
magnetization as:
M⊥(t) = M0,⊥ · e
− t
T∗2 (2.27)
M‖(t) = M0 −
(
M0 −M‖(0)
)
e
− t
T1 (2.28)
with M0 being the magnitude of the initial magnetization ~M in thermal equilibrium (i.e. "fully
relaxed"). The rotating perpendicular magnetizationM⊥(t) creates a time-dependent magnetic
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flux in the xy-plane. If a receive coil is placed around it, M⊥(t) induces a voltage Uind(t). This
voltage is the actually measurable NMR signal. With ρ(~r) being the spatial distribution of
nuclear spins, the NMR signal of a volume V is:
S(t) = Uind ∝
∫
ρ(~r) · eiω0tdV (2.29)
Due to the transversal T ∗2 relaxation, the measured NMR signal decays exponentially, which is
known as the free induction decay (FID):
S(t) = A0 · eiω0te
− t
T∗2 (2.30)
The Fourier transformation (FT) of the FID yields a Lorentzian line function in the frequency
domain. Its full width at half maximum (FWHM) is Γ = 2/T ∗2 . The detected FID and the
Fourier transform is illustrated in Figure 2.2.
As depicted in Figure 2.3, the dephasing due to local field inhomogeneities ∆B0 can be reversed.
A 180° pulse played out after the time t = TE/2 will result in a spin echo reaching its maximum
amplitude at t = TE. TE is the so called echo time.
time t
e
− t
T∗2
0
M⊥(t)s
ig
na
l[
a.
u.
]
ω0
Γ = 2/T ∗2
FT
ω
Figure 2.2: The NMR signal decays exponentially due to T ∗2 relaxation. The Fourier transform (FT)
of the free induction decay (FID, on the left) yields a Lorentzian lineshape at the frequency offset ω0
(right).
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Figure 2.3: Spin echo in the rotating
frame. (a) The equilibrium magneti-
zation is aligned to z-direction. (b) A
90° pulse flips the magnetization in the
xy-plane. (c) Dephasing and loss of co-
herence of the spin packages decreases
the magnetization. (d) A 180° pulse in-
verts the magnetization in the xy-plane.
(e) Rephasing of spin packages leads to
a build up of the spin echo. (f) Spin
echo reaches its maximum amplitude at
t=TE. (g) Time evolution of the signal
and spin echo.
Image reproduced with kind permission
from Windschuh ([28, p. 7]).
2.3 Chemical shift
Each nucleus is shielded from the static magnetic field B0 by its surrounding electron cloud.
Protons bound in molecules therefore experience a local magnetic field:
Bloc = B0 + ∆B = B0(1− σ) (2.31)
with the dimensionless shielding constant σ. Bloc results in a shift of the resonance frequency,
ωloc = γB0(1 − σ). This shift is called chemical shift due to its strong dependence on the
chemical environment. A field strength independent representation of the chemical shift is
given by a frequency ratio in parts per million (ppm):
δ = ω − ωref
ωref
· 106 (2.32)
with the reference frequency ωref . Usually, tetramethylsilane (TMS) is used in MR spectroscopy
as a reference substance for protons. However, in CEST experiments the reference frequency
is set to free water, which has a chemical shift of about 4.7 ppm with respect to TMS [22]
(i.e. δwater = 0 ppm). By convention, the direction of the frequency axis is displayed reversely
(cf. Fig. 2.2). The lower frequencies are referred as upfield, while downfield refers to higher
frequencies.
2.4 MR imaging
The above descriptions only allow the investigation of a small and homogeneous sample (i.e.
single voxel). In order to obtain a spatial encoding, a spatially dependent magnetic field is
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required. In magnetic resonance imaging (MRI), this is realized by an additional magnetic
gradient field ~G:
~B(~x) = B0 · ~ez + (~G · ~x) · ~ez (2.33)
ω(~r, t) = γ
(
B0 + ~G(~r, t) · ~ez
)
(2.34)
where the vector ~x is a point in space. The spin’s position, ~r, is encoded by their effective
resonance frequency (Eq. 2.8). The orientation of the gradient field is aligned parallel to the
static magnetic field (~G‖ ~B0) in order to not induce a precession of the spin packages.
2.4.1 k-Space
Due to the gradient field, the NMR signal (Eq. 2.29) in the rotating frame becomes:
S(~r, t) ∝
∫
ρ(~r)eiγ ~G(t)~rtd~r (2.35)
The gradient field results in an additional dephasing of the NMR signal. The spatial information
of the spins is thereby encoded in an accumulated phase. The zeroth gradient moment is
defined as the vector ~k:
~k = γ2pi
∫ t
0
~G(τ)dτ (2.36)
which yields in Equation 2.35:
S(~k(t)) ∝
∫
ρ(~r)ei~k(t)~rd~r (2.37)
Thereby, the NMR signal S(~k(t)) is linked to the Fourier transformation of the spatial spin
distribution ρ(~r):
ρ (~r(t)) ∝
∫
S
(
~k(t)
)
ei
~k(t)~rd~k (2.38)
2.4.2 Spatial encoding
The k-space represents the spatial frequency domain of an image. The image contrast is stored
at the k-space center, whereas information of sharp edges are stored in the periphery. The
k-space acquisition is briefly described in the following.
Slice selection
A linear gradient in z-direction G(z) = Gz · z yields the Larmor frequency:
ω0 = γ(B0 +Gz · z) (2.39)
An image slice can then be selected with an RF pulse of bandwidth ∆ωRF . The use of a sinc
pulse results in a rectangular excitation pattern in the frequency domain with a thickness:
∆z = ∆ωRF2piγGz
(2.40)
The center frequency of the pulse defines the slice position.
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Phase Encoding
The slice selection initiates the precession of spin packages around the z-axis. The phase
relation of the spins can locally be changed on the y-axis by another gradient, Gy, which is
activated before the signal acquisition. The y-position is then encoded in the phase of the spin
packages. Multiple phase encoding steps are required to acquire the full k-space.
Frequency Encoding
A third gradient is applied during the actual readout (i.e. when the signal is detected and
converted from an analog to digital information). This gradient in x-direction (Gx) encodes the
Larmor frequencies of the phase-encoded spin packages. Thereby, a spectrum of frequencies is
recorded. These three gradients enable the acquisition of the k-space of one imaged slice.
2.4.3 Gradient echo imaging
Adequate dephasing and rephasing of spin packages by the gradients can generate gradient
echoes. These echoes can be formed faster than spin echoes and are therefore used for a quick
image acquisition. The timing of the gradients in a fast low angle shot (FLASH) sequence is
schematically depicted in Figure 2.4. The magnetization is flipped to the y’-axis with short
excitation pulses by the flip angle α. One k-space line is then acquired in one iteration of the
phase encoding gradient. This period is called repetition time (TR). In order to minimize
stimulated echoes negatively affecting the signal acquisition, spoiling gradients are used for
dephasing of residual magnetization in the xy-plane.
Figure 2.4: Illustration a FLASH (fast
low angle shot) gradient echo sequence.
Acquisition of the gradient echo at TE
enables a short repetition time (TR)
and a quick acquisition of the whole k-
space. The gradients Gx,y,z encode the
spatial information (readout, phase en-
coding and slice selection, respectively).
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2.5 Lipids in MRI
The word fat is often used for both, the adipose tissue and the chemical component itself.
Chemically, fats are long-chain triglyceride molecules consisting of three fatty acid chains.
Triglycerides are a subgroup of lipids, which are generally defined as a biomolecule soluble
in nonpolar solvents [29]. Adipose tissue refers to tissues that mainly store triglycerides in
the body. Hydrogen atoms in lipids are nestled within aliphatic side chains among carbon
atoms. Due to their different electron shielding, they have a chemical shift with respect to
water and contribute to MR signal with different frequencies. Triglycerides are the main source
of the signal, while phospholipids in the cell membrane do not effectively contribute due to
a very short T2 relaxation time. Others, e.g. cholesterol esters or free fatty acids have a low
abundance in vivo [30] .
An exemplary 1H spectrum of fat tissue in the human breast acquired at 7 T is shown in
Figure 2.5 [31]. Ten resonances were resolved by means of MR spectroscopy. The different
lipid peaks are assigned to their corresponding chemical position in the displayed triglyceride
molecule. The resonance of highest amplitude is methylene, i.e. -(CH2)n- groups, resonating at
1.3 ppm. The chemical shift between water and this main lipid peak is thereby δω = −3.4 ppm.
In contrast to water, which is a small and thus fast rotating molecule, triglycerides move slowly.
Thereby, T1 relaxation is more efficient and much shorter than T1 of water. Reported literature
values for relaxation times of human breast tissue obtained at 7 T are listed in Table 2.1.
Figure 2.5: Proton spectrum acquired in adipose tissue in a young healthy woman at 7 T. The letter
assignment of lipid peaks is also marked on their corresponding position in the triglyceride molecule.
Methylene, i.e. -(CH2)n- groups, resonate at 1.3 ppm and present the main signal source. Image
reproduced with written permission from Dimitrov et al., MRM 2012; 67(1):20-26 [31].
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Table 2.1: Bibliographical references for relaxation times of water and the main lipid peak (methylene)
obtained at 7 T in the human breast. Methylene resonates at 1.3 ppm and contributes the most signal
(cf. Fig. 2.5, peak marked with B). The apparent T2 includes relaxations due to B0-inhomogeneities
but no J-coupling.
T1 [ms] apparent T2 [ms] study
water 2265± 65 35.5± 5.0 Haddadin et al.[32]
methylene 549± 16 52± 17 Dimitrov et al. [31]
The effect of lipid signals on MR GRE imaging is presented in the following. Furthermore, the
standard approaches to avoid or suppress fat signals in MRI are briefly described.
2.5.1 Chemical shift imaging artifact
In the presence of fat, the slice selection gradient will also act on the lipid resonances. The
excitation pulse designed to excite water protons will then additionally excite protons bound
in fat but at a different position. The gradient field strength of the slice selection gradient
is typically in the order of Gz ≈ 10 mTm . With respect to the main lipid peak (i.e. CH2), the
resulting excited slice will be shifted by ∆ωγGz ≈ 2.4 mm.
As described in the previous sections, all excited protons will begin to precess around the
z-axis. Additionally, the frequency encoding gradient during readout causes a mismatch of the
acquired fat and water image in frequency encoding direction. The readout bandwidth per
pixel BW is directly correlated to the shift ∆s by:
∆s = ∆ω · γB0
BW
(2.41)
For a readout bandwidth of 300 Hzpix at 7 T, the shift is ∆s ≈ 3.4 pix.
Echo time dependency
The chemical shift imaging artifact is dependent on the chosen TE. Due to a different chemical
shift, lipid signals perform a phase cycling of the duration 1/∆f (∆f is the frequency difference
in Hz). Thus, the phase cycling period at 7 T is about 1 ms. This results in a TE-dependent
phase relation of water (W) and fat (F) signal and consequently, TE-dependent image intensities.
Figure 2.6 shows image intensities acquired for a range of TE in the breast of a healthy woman
at 7 T. Periodic changes for over two complete phase cycling periods of water and fat were
observed. The special case of a parallel alignment is referred to as in-phase (SIP = W + F ),
while the anti-parallel is referred to as opposed phase (SOPP = W − F ).
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Figure 2.6: Fully relaxed M0 images as a function of the echo-time TE acquired at B0=7 T. The
phase relation of water and fat is TE-dependent, resulting in periodic changes of the image intensities.
The in-phase condition, i.e. the parallel alignment of water and fat in the xy-plane, varies in different
regions of interest (marked in the left) due to field inhomogeneities in the breast.
2.5.2 Methods to deal with fat signal
Image interpretation is complicated by the superposition and mismatch of the fat and water
signals. Several techniques were developed to compensate for fat signal contributions. Most
of them intent to eliminate lipid signals originating from resonances around the main lipid
peak, as they make up most of the fat signal. Standard approaches are briefly described in the
following. The reader is however advised to consult further literature for an in-depth description.
The standard procedure is to suppress the dominant methylene group by fat suppression
pulses. Frequency selective pulses are played out prior to the acquisition of the signal and
suppress the fat signal. Spoilers are used to dephase the fat [21].
Another approach utilizing the phase cycling differences of water and fat is the water ex-
citation [21, 33]. The excitation pulse is replaced by binomial pulses. For example, two
appropriately timed and broadband 45° excitation pulses are used. The first one flips both,
fat and water. The second pulse is played at an anti-parallel alignment of water and fat.
Ideally, fat is flipped back into z-direction and water is flipped into the xy-plane. No dephasing
gradients (spoilers) are required for this approach.
The inversion recovery approach utilizes the different T1 relaxation times of water and fat
(see Tab. 2.1). A 180° pulse inverts all the proton spins and they begin to recover (cf. Eq. 2.28).
The readout is timed to the zero-crossing of the fat signal [34]. However, this method yields a
reduced water signal.
The TE-dependent phase relation can be utilized in Dixon-based water-fat-separation
approaches [35]. In a simplified description, two images have to be acquired, once at an
in-phase TE (SIP ) and a second one at an opposed-phase TE (SOPP ). The water-only and
fat-only images can then be calculated by:
F = 12 · (SIP − SOPP ) (2.42)
W = 12 · (SIP + SOPP ) (2.43)
B0-inhomogeneities will affect the in-phase and opposed-phase condition (cf. Fig.2.6). In order
to account for that, at least three echoes have to be acquired [36]. To further improve the
13
2 Physical and anatomical basics
signal separation, lipid signals from all resonances have to be accounted for in the separation
model. This multi-echo-Dixon approach (mDixon) requires the acquisition of multiple images
at varying TE [37].
2.6 The human breast
In the following, the anatomy of the female human breast is briefly described. Within this
thesis, a potential correlation of amide CEST MRI to the phase of the menstrual cycle was
investigated. Therefore, the hormonal fluctuations during the menstrual cycle are shortly
outlined. The reader is however referred to literature for deeper anatomical and physiological
insights [38–40].
2.6.1 Anatomy
The female breasts (lat. mammae) contain the mammary gland with the main function of
milk production for nurturing a baby. They overlay the pectoralis muscles and are covered by
skin tissue. Breasts are part of the secondary sex characteristics and develop during puberty.
The mammary gland is composed of glandular tissue and variable amounts of fat. The glandular
tissue is divided into compartments, the so-called mammary lobes. Each breast consists of
about 5 to 20 lobes. They secret into the mammary tubules forming the milk ducts which
converge on the nipple (lat. mammilla) to the outside. The whole gland and the network of
milk ducts is covered by subcutaneous fat and connective tissue. The anatomy of the female
breast is schematically illustrated in Figure 2.7. Milk is only produced in response to hormonal
signals which are initiated after giving birth [39].
Figure 2.7: Schematic illustration of the anatomy
of the female human breast. The arrows depict the
following structures:
(1) Chest wall
(2) Pectoralis muscles
(3) Mammary gland (lobules)
(4) Mammilla
(5) Areola
(6) Milk duct
(7) Adipose tissue
(8) Skin
Original author: Patrick J. Lynch1.
1Original author: Patrick J. Lynch. Reworked by Morgoth666 to add numbered legend arrows. (https:
//commons.wikimedia.org/wiki/File:Breast_anatomy_normal_scheme.png), „Breast anatomy normal
scheme“, https://creativecommons.org/licenses/by/3.0/legalcode.
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Figure 2.8: Hormonal changes during the menstrual cycle. The menstrual cycle can be divided into
two phases: Follicular phase and luteal phase. Follicle stimulating hormone (FSH) affects the ovarian
in the follicular phase, luteinizing hormone (LH) triggers the ovaluation which is followed by the luteal
phase. Original author: Isometrik2.
2.6.2 Hormonal changes during the menstrual cycle
Although the mammary gland lactates only during nurturing of infants, hormonal fluctuations
during the menstrual cycle affect breast tissue of healthy premenopausal and non-lactating
women as well. Hormonally induced changes in breast tissue vascularization were reported
[41] as well as histological changes of breast tissue [42]. Fluctuations of the interstitial and
intracellular water content introduce morphological changes [43].
The menstrual cycle is a regular and natural change in the uterus and ovaries that enable a
potential pregnancy. It begins with the first day of menstruation and ends one day before
the next cycle starts. One cycle is typically 28± 3 days long. The first half of the cycle is
known as the follicular phase in which ovarian follicles are stimulated by the follicle stimulating
hormone (FSH). The level of the estrogen estradiol rises to the end of the follicular phase,
stimulating the production of the luteinizing hormone (LH). The LH initializes ovaluation
at around the 14th day of the cycle and the mature egg is released into the oviduct. The
second half of the cycle is know as the luteal phase. LH and FSH interact with the growth of
the follicle. If no fertilization occurs, progesterone levels drop and the next menstruation is
triggered. Fluctuations of the different hormones and their affect on the body temperature,
uterus and the ovum are given in Figure 2.8.
2Original author: Isometrik (https://commons.wikimedia.org/wiki/File:MenstrualCycle2_en.svg), „Men-
strualCycle2 en“, https://creativecommons.org/licenses/by-sa/3.0/legalcode.
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3 | Magnetization Transfer and
CEST
This chapter governs the principles of magnetization transfer and chemical exchange saturation
transfer (CEST) from a physical point of view. The reader is referred to review articles for
more insights on magnetization transfer and CEST theory [8, 44, 45] and to dissertations for
additional understanding in quantitative CEST MRI [28, 46].
3.1 Magnetization transfer processes
Additionally to the relaxation processes governed by the Bloch equations (cf. Sec. 2.2.2),
interactions between different spin systems might occur. In the following, a brief description
of the transfer of magnetization between two pools is given. A pool i is defined as a spin
system of the same physical properties, i.e. resonance frequency δi, relaxation properties and
identical exchange rates kij to other pools. Solutes (dubbed s) are less abundant than water
(w), which represents the main pool. The magnetization transfer of such a two pool system is
schematically illustrated in Figure 3.1. The magnetization transfer in aqueous media can in
principle be attributed to three processes:
Chemical exchange
Between two pools, chemical reactions can induce a physical exchange of protons. Magneti-
zation can be transferred since quantum mechanical properties of the spins are not affected
by the exchange and the changing chemical environment. This process is known as chemical
exchange (CE) [47].
Dipolar interaction
A coupled spin system is formed by spins in close proximity. Dipolar interactions between
coupled systems result in a magnetization transfer. This can either lead to a cross relaxation or
an enhancement of magnetization of one pool. This process is known as the nuclear Overhauser
effect (NOE) [48].
Molecular interaction
Depending on the macromolecular environment, molecules can form a free or a bound motion
state. A conformational transition between states of motion can alter the properties of bound
protons within the molecules, which in return leads to an exchange of magnetization.
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Figure 3.1: Schematic illustration of the two-
pool model for water and a less abundant so-
lute. The pools are defined by the resonance
frequency δ of the spins and their relaxation
rates R1 and R2. The exchange rate k charac-
terizes the exchange between the two pools.
water
water
solute
R1w
R2w, ω1 R2s, ω1
R1s
kws
ksw
3.1.1 Bloch-McConnell equations
The Bloch equations (cf. Sec. 2.2.2) can be expanded with magnetization transfer terms. This
yields a set of coupled differential equations, the Bloch-McConnell equations: [49].
d
dt
Mxw = −∆ωwMyw −R2wMxw + kswMxs − kwsMxw
d
dt
Myw = +∆ωwMxw −R2wMyw − ω1Mzw + kswMys − kwsMyw
d
dt
Mzw = −ω1Myw −R1w(Mzw −M0,w) + kswMzs − kwsMzw
d
dt
Mxs = −∆ωsMys −R2wMxs − kswMxs + kwsMxw
d
dt
Mys = +∆ωsMxs −R2wMys − ω1Mzs − kswMys + kwsMyw
d
dt
Mzs = −ω1Mys −R1s(Mzs −M0,s) − kswMzs + kwsMzw
(3.1)
The Bloch-McConnell equations describe the dynamics of magnetization of the two pools w
and s during RF irradiation with the frequency ω1 = γB1. The shift between the resonance
frequency of the pool, δi and the frequency ∆ω of the RF irradiation is ∆ωi = ∆ω − δi.
As nomenclature, the uppercase ∆ refers to the frequency shift of RF irradiation relative
to a reference. The lowercase δ is assigned to a chemical shift of a pool relative to water.
R1,i := 1T1,i and R2,i =
1
T2,i
represent the relaxation rates of the corresponding pools. M0,i
is the equilibrium magnetization. The exchange rate ksw describes transfer from solutes to
water ( s→ w) and kws describes the counter transfer ( s← w). In equilibrium, the following
relation is valid:
ksw ·M0,s = kws ·M0,w (3.2)
The forward transfer rate can be formulated as kws = fs · ksw, with the relative population
fraction fs = M0,sM0,w . This is also known as the relative concentration. The set of equations can
be expanded for the description of multiple solute pools exchanging with the water.
3.1.2 Chemical exchange
Chemical exchange of hydrogen bound in solutes, metabolites or proteins with the bulk water
is regulated by acid-base reactions. The exchange rate ksw is dependent on the chemical
environment, namely pH, temperature T and the buffer concentration and type [50, 51]:
ksw(pH, T ) = kbase(T ) · 10pH−pKw(T ) + kacid(T ) · 10−pH + kbuffer (3.3)
with pKw being the temperature dependent dissociation constant of water. kbase, kacid and
kbuffer are the base, acid and buffer catalyzed reaction rates, respectively. Exchange rates
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of amide and amine protons are mainly base-catalyzed in in vivo like systems [52]. The
temperature dependence of the reaction rates k in Equation 3.3 are governed by the Arrhenius
Law [53, 54]
k(T ) = k(298.1 K) · exp
(
Ea
R
( 1
298.1 K −
1
T
))
(3.4)
with the activation energy Ea and the universal gas constant R. The exchange rate is therefore
dependent on the chemical environment and character of the functional group.
3.1.3 Dipolar coupling
Spin systems in close proximity interact via dipolar coupling. Two coupled proton spins of
I = 12 couple to S = 0 or S = 1. Four spin states of the coupled spin system |ws〉 exist in an
external magnetic field, which are depicted in Figure 3.2. Fluctuations in the local magnetic
field due to molecular tumbling can induce transitions in a two-spin system of spins w and
s. Each transition is associated by a probability W , which is dependent on the interaction
distance r and the correlation time τc. The correlation time is the rotation duration of a
molecule around an arbitrary axis. Magnetization is transferred in cross relaxation pathways
of flip-flip or flop-flop transitions (W0,ws) and flip-flop transitions (W2,ws). In this context, the
cross relaxation rate σ = W2,ws −W0,ws is equivalent to a chemical exchange rate (σ = −ksw)
[48].
Figure 3.2: Energy levels of a dipolar coupled two-
spin system in a static magnetic field. Transition
between the spin states |ws〉(w, s =↑, ↓) is associ-
ated with the probability W . Magnetization can be
transferred via the relaxation pathways W0,ws and
W2,ws.
↓↓
↑↑
↑↓↓↑
W1,s W1,w
W1,w W1,s
W0,ws
W2,ws
3.1.4 Exchange-relayed NOE
Proteins and other larger biomolecules have a high abundance of hydrogen leading to intra-
molecular interactions of the proton spins. Sequences of flip-flop transitions can transfer
magnetization for long distances and multiple pools, which is also known as spin diffusion.
This also enables the magnetization transfer from non-exchanging hydrogen to other protons
bound to the protein that are in chemical exchange with the water. This indirect transfer
is known as the exchange-relayed NOE (rNOE) and is the dominant pathway for dipolar-
coupling-based exchange with water protons [55]. The indirect magnetization transfer from
non-exchanging protons to the water is illustrated in Figure 3.3.
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Figure 3.3: Schematic illustration showing intra-
and intermolecular magnetization transfer path-
ways in a solute proteine. Red arrows indi-
cate chemical exchange (CE). Dipolar coupling
of bound protons with CE groups is indicated by
a blue arrow. A light blue arrow shows dipolar
coupling of two bound protons. Adapted from
reference [55]
3.1.5 Semi-solid macromolecular magnetization transfer
Relevant for in vivo applications are the interactions between the macromolecular matrix and
the water. The macromolecular matrix is composed of large and semi-solid components of a
cell, e.g. the cell membrane or cytoskeleton. The so called semi-solid magnetization transfer is
referred as MT 1. The transversal relaxation time T2 is in the order of microseconds due to
the rigid structure of the macromolecular matrix, thus preventing a direct detection. Water
molecules can bound for a short period of time at the surface of the matrix. The bound
state increases the correlation time due to immobilization and enables inter-molecular NOE.
Magnetization is transferred to the water pool via diffusion after unbinding. Additionally to
transfer pathway via intermolecular NOE, rNOE processes contribute to the MT as well.
3.1.6 Functional exchanging groups that are abundant in human tissue
Within this thesis, particularly the amide but also amine protons were of interest. Amide
protons origin in the peptide bond (i.e. -NH) and stand in CE with water protons. They
resonate in the downfield at δωs = 3.5 ppm. Amine protons can be found in proteins or
metabolites (-NH2). A list of functional groups that are abundant in human tissue and
exchange magnetization with the water is provided in Table 3.1. Literature values for exchange
rates are given.
Table 3.1: Overview of exchanging functional groups that are abundant in human tissue. The resonance
frequency and literature values for exchange rates are provided. Amine and amide protons exchange
chemically with the water while aliphatic and aromatic bound protons transfer magnetization via rNOE
processes. References: 1: Zhou et al. [52]; 2: Liu et al. [56]; 3: Liepinsh and Otting [47]; 4: Xu et al.
[57]; 5: Friedman et al. [50]; 6: Goerke [58] 7: Jin and Kim [59].
Functional group origin δωs [ppm] ksw[Hz]
amide 1,2 -NH proteins 3.5 28.6-280
amine 3 -NH2 proteins/metabolites 2.0 700-10000
aliphatic 4,5 proteins -5 to -1 5-30
aromatic 6,7 proteins 1 to 5 2-3
1Other studies used the acronym ssMT.
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Chemical exchange saturation transfer (CEST) enables the indirect detection of protons in
solutes (e.g. metabolites, peptides or proteins) of low concentration in the millimolar range. In
a CEST experiment, the signal of protons pools is enhanced via an accumulation of saturated
magnetization in the water pool (c ≈ 55.5 mol). This utilization of the magnetization transfer
yields an indirect signal gain, the proton transfer ratio (PTE). The PTE is linearly dependent
on both exchange rate and relaxation time:
PTE ≈ ksw · T1,w (3.5)
3.2.1 The CEST experiment and the Z-spectrum
Two things are required to perform a CEST experiment: First, the magnetization of the
solute pool is saturated by frequency selective RF saturation. During the saturation block,
magnetization is transferred to the bulk water pool. Second, the subsequent readout of the
modified water signal follows.
In CEST experiments performed on an MR spectrometer, saturation is achieved by a continuous
wave (cw) RF irradiation.The parameters amplitude B1 = ω1/(2γpi), duration tsat and offset to
water ∆ω define the saturation block. In order to achieve sufficient accumulation of saturation
in the water, tsat  1/ksw has to be fulfilled. The duration tsat is usually in the order of hundred
milliseconds to several seconds. On-resonant saturation on the pool s leads to a transfer of
saturated magnetization to the bulk water pool. Thereby, the equilibrium magnetization Mw,0
is decreased to Mz,w(∆ω) and detected in the subsequent water signal acquisition. This is
depicted in Figure 3.4 A. Although the name CEST implies that magnetization transfer occurs
solely due to CE, other transfer pathways with corresponding exchange rates and frequency
shifts are included as well. This process of RF saturation and water signal acquisition is
repeated multiple times at varying offsets ∆ω (Fig. 3.4 B). If the saturation frequency is
on-resonant on the water, the water pool w will be directly saturated. This effect is defined
as spillover or direct water saturation (DS). By normalization of all Mz,w(∆ω) by Mw,0 the
Z-spectrum is obtained:
Z(∆ω) = Mz,w(∆ω)
Mz,0
(3.6)
An exemplary Z-spectrum of a two-pool system is shown in Figure 3.4 C. Within this thesis,
CEST experiments were combined with MRI (cf. Sec. 2.4). The images encode the water
signal spatially and therefore allow a voxel-wise calculation of Z-spectra.
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Figure 3.4: (A) Saturation block and signal acquisition in a CEST experiment. This is repeated
for varying frequency offsets ∆ω (B). The normalization by the equilibrium magnetization yields the
Z-spectrum (C). The exchanging pool resonates at δωs = 3.5 ppm. Per convention, the frequency axis
is plotted reversely.
3.2.2 Analytical solution of the Bloch-McConnell equations
An analytical solution of the first-order linear differential Bloch-McConnell equations can be
obtained by an eigenspace approach [44, 60, 61]:
~M(t) =

Mxw
Myw
Mzw
Mxs
Mys
Mzs

=
6∑
n=1
eλnt~νn + ~M ss (3.7)
with the eigenvectors ~νn and the eigenvalues λn of the two-pool magnetization vector ~M(t)
and the steady-state solution ~Mss [44, 61]. A sufficiently long saturation tsat  1/R2,w allows
to neglect all eigenvalues except λ1, thus presenting the relevant contribution to ~Mw [60].
Moreover, the eigenvector ~ν1 is co-linear to ~Beff , the effective magnetic field (Eq. 2.21). The
eigenvalue can be approximated by:
λ1 = −R1ρ (3.8)
with the longitudinal relaxation rate in the rotating frame R1ρ [61]. Magnetization transfer
can be described as an additional relaxation pathways. For a two-pool system, the exchange-
dependent relaxation rate Rex addresses the relaxation due to exchange and R1ρ is given
by:
R1ρ(∆ω) = Reff (∆ω) +Rex(∆ω) (3.9)
with the relaxation of the water pool Reff . By defining θ = arctan
( ω1
∆ω
)
the angle between
~Beff and ~B0, the water proton relaxation rate in the rotating frame becomes:
Reff (∆ω) = R1w cos2 θ +R2w sin2 θ = R1w + (R2w −R1w) · ω
2
1
ω21 + ∆ω2
(3.10)
The chemical exchange or dipolar interaction can be understood as a spectrally selective
relaxation pathway to the water magnetization in the rotating frame. After a cw saturation
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for tsat, the Z-spectrum is:
Z(∆ω, tsat) = (cos2 θ · Zinitial − Zss) · e−R1ρtsat + Zss (3.11)
which becomes in the steady-state:
Zss(∆ω) = cos
2 θR1,w
R1ρ(∆ω)
(3.12)
The Z-spectrum at ∆ω = 0 ppm (DS) can then be calculated by Rex = 0:
ZssDS,LS(∆ω) =
cos2 θR1,w
Reff (∆ω)
= 1−
Γ2w
4
Γ2w
4 + ∆ω2︸ ︷︷ ︸
Lw
(3.13)
which was transformed to a Lorentzian function Lw with the FWHM Γw = 2ω1
√
R2w
R1w
. The
exchange dependent relaxation Rex can as well be transformed into a Lorentzian-shaped
function.
Rex(∆ω) = Rmaxex
Γ2
4
Γ2
4 + (∆ω − δωs)2
(3.14)
In the above equation, the back exchange kws was neglected due to the low abundance of the
solute (M0,w  M0,s). Further, R1s  R2s and R1s  ksw was utilized [44]. The FWHM
calculates to:
Γ = 2
√
ksw +R2s
ksw
ω21 + (ksw +R2s)
2 (3.15)
The maximum Rmaxex is reached at ∆ω = δωs (cf. Fig. 3.4 C). In the large shift limit (LS),
|δωs|  ω1, it can be approximated by:
Rmaxex ≈ fsksw · α(ω1) (3.16)
with the labeling efficiency α ∈ [0, 1] describing the CEST effect:
α(ω1) =
ω21
ω21 + ksw (ksw +R2s)
(3.17)
The LS condition holds for B0 = 7 T, |δωs| > 1 ppm and B1 < 1 µT.
Multi pool system
The above equations can be expanded to describe a system of multiple pools of small size
exchanging magnetization with the water, including the exchange-relayed rNOE and semi-solid
magnetization transfer. The individual exchange processes Rex,i add up linearly:
R1ρ = Reff +
∑
i
Rex,i (3.18)
In contrast, CEST effects add up inversely to the Z-spectrum [60]:
1
Zss
= 1
Zsswater
+
∑
i
1
Zssi
(3.19)
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The individual CEST effects can all be approximated by a Lorentzian-shaped function. The
steady-state Z-spectrum is given by:
Zss(∆ω) ≈ 1− Lw −
∑
i
Li (3.20)
Within this thesis, the MT was fitted by a very broad Lorentzian function (cf. Sec. 5.7.1).
Other fitting approaches by Gaussian-shaped or Super-Lorentzian-shaped functions can also
be found in literature.
Pulsed saturation
On whole-body MRI, safety limitations prohibit the application of cw irradiation. Instead, a
series of saturation pulses have to be used. Within this work, Gaussian-shaped pulses of pulse
length tp from 15 to 100 ms were used. The spectral bandwidth (BW) of the pulses can be
approximated by: BW ≈ 1tp . The CEST sequence is depicted in Figure 5.2. The duty cycle
(DC) is defined as:
DC = tp
tp + td
(3.21)
with the inter-pulse delay td. Due to the time-dependent irradiation power during the pulses,
the Z-spectrum can be described by a mean R1ρ: The time-dependent R1ρ(∆ω, ω1(t)) is
averaged to R1ρ(∆ω), assuming Gaussian-shaped pulses [62]. Assuming R1ρtp  1 and
R1wtd  1, the steady-state solution for pulsed saturation in the LS is:
Zsspulsed,LS(∆ω) =
R1w
DC ·R1ρ(∆ω) + (1−DC) ·R1w
(3.22)
3.3 Z-spectrum analysis
An exemplary Z-spectrum acquired in the human brain at 7 T is provided in Figure 3.5. Signal
contributions from amide and amine resonances can be identified as well as ssMT, rNOE
and a broad DS. This Z-spectrum illustrates the superposition of multiple exchanging pools
and emphasizes the need of isolation of individual CEST effects for a more profound data
interpretation. Isolation of CEST effects is the separation of the exchange from the pool
of interest Rex,s from the DS Reff and contributions from all other exchanging pools (pools
i, i 6= s). The label scan Zlab is the Z-value obtained for on-resonant saturation on pool s. For
cw saturation the steady-state solution in the LS is given by:
Zsslab =
R1,w
Reff (∆ω) +
∑
iRex,i(∆ω)
(3.23)
A widespread used metric of Z-spectrum analysis is the determination of the magnetization
transfer rate by an asymmetry analysis [52], which was as well applied in studies of CEST
MRI in the human breast [13, 15, 63–65]. A label scan is simply subtracted from a reference
scan Zref . The asymmetry is obtained by defining Zlab = Z(+∆ω) and Zref = Z(−∆ω). The
symmetrical axis is per definition at DS at ∆ω = 0 ppm. It can be shown that:
MTRasym(∆ωs) = Zref − Zlab =
R1wRmaxex,s
Reff (Reff +Rmaxex,s )
(3.24)
Although this metric contains a spillover correction of zeroth order, a clear isolation of a CEST
effect is not given. This becomes also plausible in an actual acquired in vivo Z-spectrum in
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Figure 3.5 in which different effects contribute differently on both sides of the spectrum.
A more robust approach for the definition of a reference spectrum is the sum of all other CEST
effects than the pool of interest s:
Zssref (∆ω) =
R1,w
Reff (∆ω) +
∑
i,i 6=sRex,i(∆ω)
(3.25)
The pools can e.g. be identified by Lorentzian-line fitting (cf. Eq. 3.20, [66]). Zaiss et al.
introduced the inverse metric which is linearly dependent to Rmaxex,s [60]:
MTRRex(∆ω) =
1
Zlab
− 1
Zref
= Rex,s
R1w cos2 θ
(3.26)
A division of MTRRex by T1,w eliminates the scaling by R1w and yields the apparent exchange-
dependent relaxation (AREX)
AREX(∆ω) = 1
T1,w
(
1
Zlab
− 1
Zref
)
= Rex,scos2 θ (3.27)
Besides the term cos2 θ = ω
2
1
ω21+δω2s
, the AREX metric is a quantitative approach representing
the relaxation rate of the chemical exchange. The longitudinal relaxation time of water T1,w
has to be quantified in an additional measurement, e.g. by means of a saturation recover
sequence.
In the large shift limit (δω  ω1), cos2 is approximately 1, leading to the following equation:
AREX(∆ω) = fsksw
ω21
ω21 + ksw(ksw +R2s)
(3.28)
Pulsed saturation
The inverse metrics can be adapted for pulsed saturation using the DC [62]:
MTRRex(∆ω) = DC · Rex,s
R1w cos2 θ
(3.29)
AREXpulsed = DC · Rex,scos2 θ (3.30)
25
3 Magnetization Transfer and CEST
0
0.2
0.4
0.6
0.8
1
Z(∆
ω)
-6-2026
∆ω [ppm]
4 -4
chemical
exchange
rNOE
direct water
saturation
ssMT
Figure 3.5: An exemplary Z-spectrum acquired at 7 T in the human brain shows multiple CEST effects.
Contributions of amide and amine resonances via chemical exchange and aliphatic protons (rNOE)
are small compared to the direct water saturation and and semi-solid macromolecular magnetization
transfer. Reproduced with kind permission from Meissner [46].
Summary
With respect to the work presented in this thesis, the following points summarize the previous
sections and the Z-spectrum analysis:
• Magnetization transfer can be understood as an additional spectrally selective relaxation
pathway of the water magnetization in the rotating frame.
• Multiple CEST effects can be described using a pool model.
• The Z-spectrum can be approximated as a sum of Lorentzian-shaped functions repre-
senting the CEST effects.
• The AREX metric allows to isolate individual CEST effects and represents a full quanti-
tative approach to determine the CEST effect.
• The steady-state assumptions requires a sufficiently long saturation.
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4 | A novel normalization for
CEST MRI to correct for
fat-signal-induced artifacts
CEST MRI can be complicated by the presence of fat, wherein lipid signals cause an incorrect
normalization and thereby artifacts in the Z-spectrum [20]. The mammary gland of the human
breast represents an organ of high inter-subject variability in both size and fat fraction. CEST
MRI of the human breast is therefore prone to fat-signal-induced artifacts. To overcome
these artifacts, other studies have applied fat saturation [14, 64], water excitation [65, 67,
68] or used a 3pt-Dixon water-fat-separation approach [15]. Within this thesis, a novel and
alternative approach was developed enabling the correction of fat-signal-induced artifacts in
the post-processing.
4.1 CEST MRI in the presence of fat
Chemical shift [ppm]
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Figure 4.1: Proton spectra of various fat-containing samples (sunflower oil, egg yolk, cream, and lard)
were measured at the 14.1 T spectrometer, while the upper red line shows a spectrum acquired at
B0=7 T in the breast of a healthy volunteer. The proton spectra show coinciding lipid resonances of
different peak widths and amplitudes. Lipid resonances are grouped to six main signals in order to
display their phase relation in the xy-plane (cf. Fig. 4.3). The dominant lipid peak (5) originates from
methylene groups (CH2). Parameters of spectra acquisition can be found in the Appendix.
Figure 4.1 shows the proton spectra of fat-containing samples, including one acquired in the
breast of a healthy volunteer. Several coinciding lipid peaks of varying amplitudes and widths
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can be identified. In GRE imaging of fat-containing tissue and organs, the detected MR signal
is a superposition of water and lipid signals in the xy-plane. Generally formulated, the signal
S in a voxel at readout time t (i.e. at echo time, TE) is [69, 70]:
S(t) =
(
W0 +
N∑
n=1
F0,n · ei2pi∆fn·t
)
· ei2piΨ·t (4.1)
with W0 being the water signal and F0,n the amplitude of the n-th lipid peak. The index "0"
indicates a fully relaxed signal. Ψ represents the B0-inhomogeneities in that voxel (in Hz)1.
The equation above can be interpreted as a dispersion of the individual lipid signals due to
their different chemical shifts ∆fn = ∆ωn/2pi. The chemical shifts are given with respect to the
water signal (∆ωW = 0 ppm). Additionally, due to field inhomogeneities, all signals experience
a phasing. This is schematically illustrated in Figure 4.2 A. Here, the lipid resonances in the
proton spectrum were grouped to six signals for simplification (cf. Fig. 4.1), although ten lipid
resonances can be resolved by MR spectroscopy of the human breast at B0=7 T[31].
The phase relations of MR signals in the xy-plane become more construable when formulated
in a vector notation. In general, the fully relaxed fat signal ~F0 is the collective sum of N
signals, ~Fn:
~F0 =
N∑
n=1
~Fn (4.2)
An unsaturated and fully relaxed image ~S0 is then the superposition of a water ~W0 and a fat
~F0 image:
~S0 = ~W0 + ~F0 (4.3)
As learned from Equation 4.1, the phase relation between ~W0 and ~F0 will ultimately be affected
by the choice of the acquisition time t, or, with respect to GRE imaging, the parameter
TE. The special case of a parallel alignment of ~W0 and ~F0 is defined as in-phase, while the
opposed-phase defines an anti-parallel orientation.
Figure 4.2: The phase relations of lipid signals in the xy-plane with and without saturation are
depicted schematically. A: The individual lipid resonances, ~Fn are dephased at readout. They sum up
to ~F0. B: The cumulative fat signal after partial lipid saturation, ~F (∆ω) , is changed in phase and
amplitude compared to the fully relaxed fat signal, ~F0.
In a CEST experiment, the amplitude of the water signal ~W0 decreases, its phase is however
conserved. Hence, the CEST effect at the frequency offset ∆ω can be described by the scalar
α:
~W (∆ω) = α(∆ω) · ~W0 (4.4)
1For simplicity, R∗2 relaxation is neglected, since TE  T2.
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with α(∆ω) ∈ [0, 1]. If the frequency offset ∆ω during CEST coincides with lipid resonances, fat
saturation occurs. The partial lipid saturation can be described by the scaling βn(∆ω) ∈ [0, 1].
Consequently, the saturation of lipids will alter both, phase and amplitude of the collective fat
signal:
~F (∆ω) =
N∑
n=1
βn(∆ω) · ~Fn (4.5)
This is schematically depicted in Figure 4.2 B. The acquired saturated image ~S (∆ω) is again
the sum of water (Eq. 4.4) and fat signals (Eq. 4.5):
~S(∆ω) = ~W (∆ω) + ~F (∆ω) (4.6)
= α(∆ω) · ~W0 +
N∑
n=1
βn(∆ω) · ~Fn (4.7)
Therefore, the phase and magnitude of the measured signal ~S (∆ω) changes compared to the
unsaturated ~S0. This change of orientation is illustrated in Figure 4.3.
Figure 4.3: The phase relations of MR signals in the xy-plane with and without saturation are depicted
schematically. The detected signal is a sum of water and lipid signals. The phase and magnitude of the
pre-saturated image, ~S (∆ω) , change compared to the fully relaxed image ~S0.
Conventionally, a Z-spectrum is acquired by the normalization of an image acquired after
pre-saturation by an unsaturated one:
Zconv(∆ω) =
∣∣∣~S(∆ω)∣∣∣∣∣∣~S0∣∣∣ =
∣∣∣α(∆ω) · ~W0 + ~F (∆ω)∣∣∣∣∣∣ ~W0 + ~F0∣∣∣ (4.8)
It is apparent that the equation above does not yield the desired CEST effect α. The
conventional normalization is instead affected by fat signal contribution, which leads to a
well-known artifact in the spectral region of exchange-relayed nuclear Overhauser effects (rNOE,
cf. Sec. 3.1.4): The Larmor frequency of the large methylene peak (δω ≈ −3.4 ppm) coincides
with rNOE signals. The partial saturation of the methylene will decrease ~F (∆ω = −3.4 ppm)
significantly, leading to a dip in the Z-spectrum. This has been identified as the source of
so-called pseudo rNOE artifacts in the upfield Z-spectrum by Lu et al. [20]. An exemplary
Z-spectrum exhibiting a prominent pseudo rNOE artifact is shown in Figure 4.4.
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Figure 4.4: Exemplary Z-spectrum av-
eraged in the gland of a healthy volun-
teer to demonstrate the pseudo rNOE
artifact.
Zhang et al. investigated the influence of the echo time on the Z-spectrum appearance [63].
They demonstrated that not only the pseudo artifacts are influenced by the choice of TE, but
also the direct water saturation (DS, i.e. at ∆ω = 0 ppm). Both, the source of the pseudo
rNOE artifact and the dependence on TE, is explainable by the derived general vector notation
of MR signals and their phase relations during the CEST experiment. The understanding
of the origin of those artifacts is directly followed by the awareness, that the application
of the asymmetry analysis (MTRasym) itself is highly questionable, if CEST is applied to
fat-containing tissues and organs.
4.2 A novel normalization correcting for fat-signal-induced ar-
tifacts
Based on three assumptions, a post-processing method will be introduced in the following
enabling the correction of APT signal for fat signal contributions.
The duration of the saturation train in a CEST experiment is usually in the order of several
seconds. If no magnetization recovers during the readout, the pre-saturation would yield
complete water saturation at ∆ω = 0 ppm. This can be expressed by:
Assumption 1: α(∆ω = 0 ppm) = 0
The technical limitations of whole-body scanners require the application of a pulsed pre-
saturation train instead of cw. Gaussian-shaped RF pulses ensure a frequency selective
saturation. Although some lipid signals resonate close to the water, no resonance coincides
with the water peak at δω = 0 ppm. One can therefore assume that the direct water saturation
does not partially saturate lipid signal. This can be formulated as:
Assumption 2: βn(∆ω = 0 ppm) = 1 ∀ n
which is equivalent to ~F (∆ω = 0 ppm) = ~F0. This allows the detection of ~F0 by the measured
residual magnetization at the frequency offset ∆ω = 0 ppm. The fully relaxed fat signal in
each voxel is thereby:
~S(∆ω = 0 ppm) = ~F0 (4.9)
By the knowledge of the fat-only image ~F0, the fat fraction FF can be estimated in a Z-
spectrum acquired with an in-phase relation of ~W0 and ~F0. The parallel alignment simplifies
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Equation 4.8 to:
Zconv, in-phase(∆ω = 0 ppm) =
∣∣∣α(0 ppm) ~W0 + ~F (0 ppm)∣∣∣∣∣∣ ~W0 + ~F0∣∣∣ =
F0
W0 + F0
=: FF (4.10)
Or in other words: The fat fraction can be calculated by the normalization of the fat-only
image ~F0 by the fully relaxed image ~S0. The fat fraction provides useful information for data
interpretation.
The fully relaxed water-only image ~W0 can be calculated by transforming Equation 4.3:
~W0 = ~S0 − ~F0 (4.11)
Since no lipid signals resonate in the spectral region of amides (i.e. at frequency offsets around
≈ 3.5 ppm), a third expression can be made:
Assumption 3: βn(∆ω ≈ 3.5 ppm) = 1 ∀ n
or in other words: the collective fat signal at frequency offsets that does not coincide with
lipid resonances is equal to the equilibrium and fully relaxed fat signal, ~F (∆ω) = ~F0. These
formulations can be used to define a novel, fat-signal-corrected CEST normalization yielding
the true CEST effect α:
Zcorr(∆ω) =
∣∣∣~S(∆ω)− ~S(0 ppm)∣∣∣∣∣∣~S0 − ~S(0 ppm)∣∣∣ =
∣∣∣ ~W (∆ω)∣∣∣∣∣∣ ~W0∣∣∣ = α (4.12)
The equations above therefore allow a post-processing based correction of the acquired data.
This correction method furthermore accounts for lipid signals of all resonances and does not
require additional measurements. All information needed is obtained by the acquisition of
the Z-spectrum. However, in order to retrieve the phase information and generally apply
Zcorr(∆ω), complex-valued images are required.
It is worth mentioning that Equation 4.12 simplifies for an in-phase relation of ~W0 and ~F0:
Zcorr,in−phase =
|S(∆ω)− S(0 ppm)|
|S0 − S(0 ppm)| =
Z − Z(0 ppm)
1− Z(0 ppm) = α (4.13)
which enables the correction of Z-spectra without the need for complex-valued image data and
hence allows the use of magnitude images.
4.3 Challenges
In order to bring the novel correction method into in vivo application and to enable relaxation-
compensated amide CEST MRI of the human breast, several challenges had to be overcome.
They are shortly described in the following.
Phase-sensitive imaging
The analysis of CEST data is usually performed on magnitude image data stored in the DICOM
standard (Digital Imaging and Communications in Medicine). Here, the obtained images are
calculated by the sum-of-squares (SOS) coil combination and saved with 12 bit depth. In order
to investigate the interplay of water and fat during a CEST experiment, the phase information
of the measurements were required. Therefore, the workflow was changed to a raw data based
analysis. This enabled the application of adaptive coil combination algorithms that preserved
the phase information and increased the overall SNR (cf. Sec. 5.3).
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Field mapping and T1 mapping of the human breast
Lipid signals contributing to MR images also affect quantitative measures such as field mapping
and T1 mapping. Robust field mapping as well as T1 mapping is required for relaxation-
compensated CEST MRI [18]. A post-processing approach was not feasible. Instead, fat
saturation was chosen to overcome lipid signals. The GRE sequence itself provides an built-in
option of fat saturation. It consists of one 90° sinc pulse played out before each k-space line,
increasing the TR by 10 ms. This option, however, is SAR costly and the duration of k-space
acquisition is significantly prolonged. To overcome this, an own fat saturation was developed.
Breast imaging at 7 T
The human breast is a deformable organ, which presents a challenge for MR acquisitions
at high fields. An imaging protocol to reduce motion artifacts had to be developed. Most
importantly, all in vivo examinations had to be synchronized to the breathing of the examined
women.
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This chapter introduces the equipment and methods used for MR imaging and data analy-
sis in this work. Furthermore, a comprehensive theory of the derived fat-corrected CEST
normalization, which comprises the core of the thesis, is given.
5.1 MR imaging systems
All MR imaging experiments performed in this work were done on a 7 Tesla whole-body MR
tomograph (MAGNETOM 7 T, Siemens Healthineers, Erlangen, Germany) at the German
Cancer Research Center (DKFZ). The static magnetic field of B0 = 6.98 T results in a resonance
frequency of ν0 = 297.155 MHz for 1H. Two coils were employed for imaging:
1. A 1Tx/16Rx bilateral diagnostic breast array by Rapid (Rapid Biomedical GmbH,
Rimpar, Germany) for phantom experiments and in vivo examinations (Fig. 5.1).
2. A 1Tx/24Rx head coil by Nova Medical (Nova medical Inc., Wilmington, USA) for
phantom experiments.
Figure 5.1: Left: Picture of the 7 Tesla whole-body MR tomograph at the German Cancer Research
Center (DKFZ) (MAGNETOM 7 T, Siemens, Erlangen. Image from [71]). Right: A picture of the
bilateral diagnostic breast array used in this work (1Tx/16Rx, Rapid Biomedical GmbH, Rimpar,
Germany). The blue mattress provides padding and increases patient comfort.
5.2 The CEST sequence
The CEST sequence consists of a pre-saturation block and a subsequent image acquisition,
which is based on a Siemens product sequence (Siemens Healthineers, Erlangen, Germany;
[72]). Saturation is achieved by a series of n Gaussian-shaped RF-pulses. Each pulse has the
duration tp and a mean amplitude B1. Its frequency offset ∆ω is changed for each image for
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the acquisition of a Z-spectrum. In between the pulses, the time delay td is used for gradient
spoiling. The duty cycle (DC) is defined by:
DC = tp
tp + td
(5.1)
The complete saturation time tsat is:
tsat = n · tp + (n− 1) · td = (n− 1) · tp
DC
+ tp (5.2)
A recovery time trec prior to the saturation pulse train can be set. In order to acquire a fully
relaxed image, it was set to trec,M0 = 12 s. For the acquisition of pre-saturated images, the
recovery time was set to trec = 0 s. A GRE sequence followed the pre-saturation to acquire the
water signal. In order to acquire a complete Z-spectrum, the saturation block was repeated for
various ∆ω. A schematic illustration of the CEST sequence is given in Figure 5.2.
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Figure 5.2: Schematic illustration of the CEST sequence. The saturation block consists of a series of
Gaussian-shaped RF-pulses with the frequency offset ∆ω, duration tp, and mean RF amplitude B1. A
spoiling is played out by the gradients in between the pulses for the duration td.
5.3 Image reconstruction
The phase information of the acquired MR images was required for the application of the
novel CEST normalization (cf. Chapter 4). Therefore, images were reconstructed based on raw
data. The MR signal obtained with multi-channel coils can be combined and reconstructed to
a single image of complex-valued intensities. A Matlab-toolbox1 providing an adaptive coil
combination algorithm was utilized for the image reconstruction [73]. In comparison to the
sum-of-squares technique, the reconstruction based on the adaptive combination algorithm
increases the SNR [73]. An advancement of the adaptive combination algorithm incorporated
phase information in the optimizing of the coil weightings, which resulted in unwrapped phases
of the reconstructed, complex-valued images [74, 75]. The effect of both algorithms on the
phase maps is demonstrated in Figure 5.3. The second, more advanced reconstruction provides
smooth and steady phase maps (cf. Fig. 5.3 C). This optimized algorithm was therefore used
for the reconstruction of all acquired data within this thesis.
1Kindly provided by Dr. Philipp Ehses, German Center for Neurodegenerative Diseases (DZNE), Bonn,
Germany.
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Figure 5.3: Fully relaxed image (A) and corresponding phase maps obtained by two sets of coil
weightings. The phase map obtained by an adaptive combination algorithm by Walsh et al.[73] shows
inhomogeneities (B). In contrast, the image reconstruction incorporating a phase unwrapping and
phasing of the image provides smooth and even phase maps (C) [73–75].
5.4 Implementation of SAR and time-efficient fat saturation
The built-in fat-saturation option of the GRE sequence was inadequate for application due
to the increased SAR and imaging acquisition time. Therefore, a SAR- and time-efficient fat
saturation was developed for T1 and field mapping2. It consisted of five 90° Gaussian-shaped
pulses prior to image acquisition. The pulses had a length of tp = 2.5 ms and a power of
B1 = 2.35µT. A spoiling time of 2 ms was placed between the pulses. The center frequency
was set to ∆ω = −3.3 ppm. The complete fat saturation block had a length of 20.5 ms.
5.5 B0 and B1 field mapping
Field mapping was performed with the water shift and B1 mapping (WASABI) method 3 [76].
The WASABI sequence consists of a rectangular preparation pulse with varying off-resonance
that induces a sinc-like oscillation pattern in the frequency domain4. The acquired and
normalized spectrum, Z (∆ω), is dependent on both transmit field power B1 and the actual
water frequency δω. Schuenke et al. suggested a rectangular pulse with a duration of tp = 5 ms
and amplitude B1 = 3.7 µT for field mapping at 3 T [76]. To increase the spectral range of
the oscillations, these settings were adapted to tp = 2.5 ms and B1 = 7 µT. The standard
sampling of Z-spectra consisted of 31 equally spaced offsets in the range of ∆ω = ±4 ppm.
The developed fat-saturation block was played out after the preparation pulse (see Sec. 5.4).
The spectrum was fit according to:
Z (∆ω) =
∣∣∣∣c− d · sin2 (tan−1 ( γ ·B1∆ω − δω
))
· sin2
(√
(γ ·B1)2 + (∆ω − δω)2 · tp2
)∣∣∣∣
(5.3)
The parameters c and d are free and describe the amplitude and modulation of the oscillation.
The B0-shift map was calculated by ∆B0 = γ ·δω. To further stabilize the fit, phase information
of the acquired images can be utilized to circumvent the calculation on positive magnitudes as
2MRI sequence programming was done within the Integrated Development Environment for MR Applications
(IDEA, Siemens Healthcare, Erlangen, Germany).
3In this thesis, B1 refers to the transmit field power. In the literature, the transmit field is sometimes referred
as B+1 .
4Only the pre-saturation block is changed, but the imaging is the same as in CEST measurements.
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in Equation 5.3.
Zphase−corr. (∆ω) =
∣∣∣~Z (∆ω)∣∣∣ · sgn{< (~Z(∆ω) · exp (−i · ∠ ( ~M0)))} (5.4)
An alternative B0 mapping approach used in this work was the internal water shift calcula-
tion in CEST experiments: The water shift was determined voxel-wise by the result of the
center frequency of the Lorentzian fit. This approach was found to be more robust in in
vivo examinations and avoided motion within the sequences.
5.6 T1 mapping
A T1-map of water is required for the calculation of relaxation-compensated CEST contrasts.
A saturation recovery sequence preparation was used for the measurement: Three adiabatic
half passage pulses of µ = 6, BW = 1200 Hz and a length of tp = 8 ms achieved complete
signal saturation. After a delay (termed trecover), five fat saturation pulses (cf. Sec. 5.4) were
played out. The recovery was sampled at 17 different recovery times5. The descending order
of recovery times supported the image reconstruction, which computes the coil weightings on
the first acquired image of an experiment. The recovery of the longitudinal signal, Mz, was
fitted by an exponential function in each voxel [77]:
M (t) =
∣∣∣M0 (1− e−t/T1)∣∣∣ (5.5)
t
Image
acquisition
≈ 400 ms
fat
saturation
20.5 ms
recover time trecover
100 ms - 15 s
complete
signal
saturation
50 ms
variable waiting time twait
whole multiple of the breathing cycle tBC
Figure 5.4: Schematic illustration of the saturation recovery sequence. The waiting time in the
beginning ensures the synchronization of the sequence to the breathing of the subjects.
In order to maintain the synchronization of the sequence to the natural breathing rhythm of
the women (cf. Sec. 5.9), a waiting time twait was introduced prior to the saturation recovery
block. It was calculated for each recovery time such that the overall waiting time before image
acquisition was a whole multiple of the breathing cycle duration, tBC :
twait = N · tBC − tsat − trecover (5.6)
with N = d tsat+trecovertBC e (5.7)
where tsat denotes the time requirement of the fat saturation block and complete signal
saturation before the recovery time (trecover). The imaging time itself (≈ 400 ms) was not
accounted for in the calculation. A schematic illustration of the recovery sequence is depicted
in Figure 5.4.
5The standard protocol consisted of the following recovery times: trecover=15 000, 10 000, 5000, 4500, 4000,
3500, 3000, 2500, 2000, 1600, 1300, 1000, 800, 600, 400, 200, and 100 ms.
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5.7 CEST evaluation
This section describes how the isolated CEST contrast is calculated on Z-spectra. Z-spectra
are obtained by the voxel-wise normalization of pre-saturated images, with or without the
developed fat correction (see Sec. 4).
5.7.1 Determination of Zlab and Zref
To isolate CEST effects and apply the inverse metric, a model was fitted to the Z-spectra6.
Fitting furthermore compensates noise and outliers in spectra. Each CEST pool n was
approximated by a Lorentzian function Ln:
Ln(∆ω) = An
Γ2n
4
Γ2n
4 + (∆ω − δn)2
(5.8)
where δn represents the center (resonance frequency) with respect to water (δwater = 0), Γn
the FWHM, and An its peak amplitude. The fit allowed the definition of the labeled Z-value,
Zlab, and the reference Zref . The complete fit serves as label Zlab, while the Lorentzian pool
of interest is excluded for the reference.
Z-spectra obtained in vivo in the human breast were fitted by a superposition of five Lorentzians
[18, 66]. This five-pool model describes effects from the direct saturation of water, the semi-
solid MT, amides, and amines. The lipid-signal-induced pseudo rNOE artifact as well as real
signals of aliphatic rNOE were fit by a combining fifth pool for simplification. Thereby, the
CEST effect of real rNOE signals could not be retrieved from the data, however, the overall
robustness of the fit itself improved. The labeled Z-spectrum is:
Zlab(∆ω) = c− (Lwater(∆ω) + LMT (∆ω) + Lamide(∆ω) + Lamine(∆ω) + LrNOE(∆ω))
(5.9)
The offset c accounts for imperfect signal recovery. The start parameters were optimized for
application in the human breast and are listed in Table 5.1.
Z-spectra obtained in the carnosine phantom were fitted by a single Lorentzian of the sole
amide resonance and a second-order polynomial background:
Zlab(∆ω) = a · (∆ω)2 + b ·∆ω + c− Lamide(∆ω) (5.10)
A table listing the start values as well as boundaries can be found in Appendix A.2.
The reference spectrum can be calculated by:
Zref, n(∆ω) = Zlab(∆ω) + Ln(∆ω) (5.11)
6All fit analysis was performed with Matlab 2017b (The MathWorks, Inc., Natick, Massachusetts, USA)
utilizing a C/C++ implementation of the Levenberg-Marquardt non-linear least squares minimization
algorithm [78].
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Table 5.1: List of start parameters of the five-pool model used for fitting in vivo Z-spectra. A complete
list with boundaries can be found in Appendix A.1.
Pool Amplitude A FWHM Γ [ppm] frequency offset δ [ppm]
water 0.90 1.4 0
amide 0 1.4 3.5
amine 0 50 2.2
MT 0 1.40 −2.0
rNOE/fat 0 1 −3.5
offset c 1
5.7.2 B0 correction of Z-spectra
Spectral shifts of Z-spectra are observable in CEST MRI at high field strengths due to the
increased B0-inhomogeneities within the imaging plane. These shifts are particularly noticeable
at the DS if its center frequency is not at ∆ω = 0 ppm. In previous works, a B0-correction
was performed. The well-established WASSR algorithm by Kim et al. was utilized to correct
Z-spectra [79]. It interpolates spectra to high spectral resolution and re-shifts to the actually
used set of frequency offsets.
However, this method is not suitable for application to CEST data in the presence of fat. The
interpolation of acquired data significantly smooths the data, potentially leading to artifacts
of CEST contrasts. A B0-correction of the investigated phase artifacts of the DS is especially
error prone. In order to avoid data manipulation, the relative B0-shift was instead accounted
for in the determination of the label and reference spectra. Zlab and Zref were calculated at
the actual frequency offset ∆ω on a voxel-by-voxel basis, by utilizing a ∆B0-map:
∆ω = ∆ωuncorr + ∆B0 (5.12)
∆ωuncorr represents the nominal saturation offset affected by a B0-shift. Non-B0-corrected
Z-spectra presented no obstacle in the fitting process itself. The robustness of the five-pool
Lorentzian fit was verified for varying start parameters in the dissertation of Windschuh [28],
which supports this alternative correction approach.
5.7.3 Calculation of the isolated amide contrast
With the knowledge of Zlab and Zref , one can obtain the apparent exchange-dependent
relaxation, the AREX contrast [16]:
AREX(∆ω) = DC
T1
·
(
1
Zlab(∆ω)
− 1
Zref (∆ω)
)
(5.13)
T1 is the longitudinal relaxation time obtained by a saturation recovery experiment and DC
is the duty cycle of the pulsed saturation. AREXamide was calculated at ∆ω = 3.5 ppm and
3.16 ppm for analysis of in vivo spectra and the carnosine experiment, respectively. AREX
maps of amine effects were calculated at ∆ω = 2.2 ppm.
5.7.4 B1 contrast correction
CEST effects depend strongly on the saturation amplitude B1[18, 44]. Due to the breast coil
design and the high field strength of 7 T, increased inhomogeneities of the transmit field are
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expected in examinations of the human breast within a comparatively small volume. As a rule
of thumb, deviations of up to ±40 % from the nominal B1 can be observed within one breast.
The correction method for B1-inhomogeneities published by Windschuh et al. was employed
(termed two-point contrast-B1 correction [18]). A spline interpolation between isolated CEST
contrast values determined in two consecutive experiments with varying saturation powers
results in the final contrast. Usually, B1 values were first set to B1 = 0.9 µT and then lowered
to B1 = 0.6µT in the subsequent examination. The reference voltage was not changed for
the two experiments in order to keep the flip angle constant. The method is valid for each
exchanging pool [18] and was applied on AREX contrast maps of amide and amine resonances.
Contrasts were reconstructed to B1,reconstr = 0.8 µT.
5.8 Phantoms
The verification of the developed fat saturation for robust field and T1 mapping was performed
in a cream containing phantom. The dairy product cream with a fat content of 30% is a cheap
and easy to handle model solution for MR experiments. Four vials filled with cream were
placed inside a MR compatible thermo flask (Coleman Jug, 1.8 l). The flask, completely filled
with saline, served for temperature stabilization.
A carnosine model solution was prepared for the in vitroverification of the novel normalization
(Sigma-Aldrich, Steinheim, Germany). The dipeptide carnosine (β-alanyl-L-histidine) has
a single exchanging amide proton at the peptide bond. It was therefore used to prepare a
one-pool CEST model solution [80]. A phosphate buffered carnosine solution (PBS, 1/15 M)
with a pH of 8.06 and a concentration of ccarnosine = 300 mM was prepared and filled into a
Nalgene 1L container. Sunflower oil was poured on top. In order to demonstrate how fat signal
contribution affects the APT signal, the imaging plane for CEST measurements was set in the
interface between the oil and carnosine solution and slightly tilted. Thereby, a fat fraction
gradient was created along the image. This is schematically illustrated in Figure 5.5. Similar
setups were used in [37] or [63]. The CEST experiment was performed at room temperature
(T = 22 ◦C).
sunflower oil
carnosine water
solution
imaging
plane
Figure 5.5: Schematic illustration of the carnosine-oil phan-
tom setup. The tilted imaging plane created a fat fraction
gradient in the images.
5.9 In vivo application
All examinations were approved by the local ethics committee of the Medical Faculty of the
University of Heidelberg and are in accordance with the relevant guidelines and regulations.
Written informed consent was received from all subjects prior to examinations. The examined
women were not pregnant nor breastfeeding. They did not use hormonal contraceptives nor
had implanted intrauterine contraceptive devices.
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5.9.1 Healthy volunteers
CEST data of four healthy premenopausal women are shown within this thesis. The age of
the examined volunteers was 31 (volunteer abbreviated as V1), 26 (V2), 23 (V3), and 23
(V4). Imaging and saturation parameters were mostly the same as in the stated protocol in
Section 5.9.4 below. If parameters had to be adapted in order to address particular questions
for the development of amide CEST MRI, they are listed in the Appendix.
Dependence of AREXamide on menstrual cycle
Breast parenchyma undergoes histologic and vascular [41–43] hormonally induced changes
during the menstrual cycle. The guidelines from the European Society of Breast Imaging
advise to perform a dynamic contrast enhanced breast MR examination between the 5th and
12th day of the menstrual cycle of premenopausal women [4]. Although diffusion weighted
MRI appears to be unaffected by the menstrual cycle [5], it is unknown whether the amide
CEST contrast underlies hormonal induced changes. To investigate a potential dependence,
V1 was examined weekly for six times, beginning at the 10th day of her menstrual cycle.
Furthermore, to explore this question within a small cohort of healthy volunteers, a clinical
pilot study started in autumn of 2018 within a collaboration of the Department of Radiology
(DKFZ) and the Department of Gynecology and Obstetrics (University Hospital Heidelberg)7.
The study plans to examine 15 healthy women once in the follicular phase (between the 2nd
and 5th day of the cycle) and a second time two weeks later (luteal phase, cf. Sec. 2.6.2).
The volunteers V2,V3, and V4 were included in this pilot study and are presented within this
thesis.
5.9.2 Patient cohort
The data of mamma carcinoma patients presented in this work are part of an ongoing clinical
patient study initiated by the Departments of Radiology (DKFZ) and Gynecology and Ostetrics
(University Hospital Heidelberg)8. The aim of this study is to investigate the feasibility of
differentiating malignant from benign tissue by means of relaxation-compensated amide CEST
MRI in the human breast and to compare the amide contrast to conventional clinical MR
images. As a first step, twelve patients are planned to be examined by the established protocol
and evaluated descriptively. In this work, three patients of this collective are presented and
listed in Table 5.2. If required and orally approved by the patients, the TSE sequence was
repeated with optimized shim and voltage settings after the CEST measurements.
Table 5.2: Data of the patient cohort presented in this work.
Patient abbrevation Age Locality Type Grading
P1 58 right invasive mucinous carcinoma G2
P2 31 left invasive ductal carcinoma G2
P3 43 right invasive ductal carcinoma G2
7Title: Evaluation of menstrual cycle dependence of CEST MRI at 7T in pre-menopausal women
8Title: Chemical Exchange Saturation Transfer (CEST) MR mammography at 7T
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5.9.3 Breast imaging and breathing synchronization
All women were imaged in head-first prone position with their arms tight. Wearing scrubs
during the examinations supported the breasts, which increased overall comfort and reduced
motion artifacts. Unilateral and transversal imaging of only one breast improved shimming
results and reduced the imaging time. If possible, imaging of the right breast was preferred in
order to avoid flow artifacts of the heartbeat.
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Figure 5.6: Schematic illustration of the breathing-induced chest motion during the CEST sequence.
The saturation duration is adapted to synchronize the CEST sequence to the breathing cycle of the
examined woman. Thereby, motion-induced artifacts as well as the non-rigid deformation of the imaged
breast are avoided. Typically, one breathing cycle is 6 to 8 seconds long.
The subjects were asked to synchronize their breathing with the acoustic rhythm of the
sequence in order to reduce motion artifacts. The motion of the chest during breathing and
the timing of saturation and imaging is schematically illustrated in Figure 5.6. The tone of the
pre-saturation is a deep and mumbling noise while the image acquisition sounds like a horn
for only 0.4 s. The examined women therefore aimed to breathe freely during saturation and
having finished exhalation before the start of image acquisition. This proceeding was preferred,
since the exhaled state is more reproducible and an almost free breathing over the course of
the whole examination was feasible.
5.9.4 In vivo examination protocol
Breast examinations were performed using the 2D GRE CEST sequence in single-slice mode
(cf. Sec. 5.2). Acquisition parameters can be found in Table 5.3. The standard CEST protocol
is listed below.
• Localizer: Images can be obtained with built-in fat suppression if the SAR limit is not
exceeded.
• Anatomical images: A multi-slice T2-weighted turbo-spin-echo (TSE) sequence for
breast morphology.
• Slice positioning:
– Patient measurement: tumor localization with the help of a radiologist.
– Volunteer measurement: the slice should intersect the mammilla to enable repeatable
slice positioning.
• Shimming: Set the adjustment volume within the gland/tumor and expand it to only
just cover the mammary gland with as little adipose tissue as possible. Avoid including
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the pectoral muscle. An exemplary definition of the adjustment volume is depicted in
Figure 5.7. During the shimming, the subjects should hold their breath for 25 s.
• Estimation of breathing rhythm: The natural breathing cycle induces periodic
changes of the water frequency. The periodicity can be estimated by manually tracking
the interactive shim for three to five respiratory cycles.
• Adjustment of reference voltage amplitude: Optimize B1 iteratively using a fat
saturated flip angle map (Siemens WIP sequence). The optimal voltage is usually
overestimated by approximately 10 % in the presence of fat.
• Test run of a CEST sequence: Test the synchronization of the sequence to the
breathing for about ten images.
• CEST with a nominal saturation amplitude of B1 = 0.9 µT
• CEST with a nominal saturation amplitude of B1 = 0.6 µT
• T1 mapping
• WASABI
The CEST measurements consisted of 75 unevenly sampled frequency offsets9. Saturation was
achieved by 297 Gaussian-shaped pulses of duration tp = 15 ms and DC = 80 %. The total
saturation time was 5.6 s, leading to a total duration of 6 s per offset including imaging. This
matched the breathing cycle of the majority of the examined women. In some cases of a longer
period, a recovery time prior to the saturation pulse train was set to enable synchronization (i.e.
trec > 0 s). The total measurement time including positioning and shimming was approximately
40 min.
Figure 5.7: screenshot of the positioning of the adjustment volume (green). It should cover as little
adipose tissue as possible and not cross the thorax.
9∆ω = 295, 300, 290, 100, 50, 20, 12, 8, 6.25, 5.25, 4.7, 4.4, 4.25, 4.1, 3.95, 3.8, 3.7, 3.6, 3.5, 3.4, 3.3, 3.2, 3.1,
3, 2.9, 2.75, 2.6, 2.45, 2.3, 2.15, 2, 1.85, 1.7, 1.55, 1.4, 1.25, 1.1, 0.95, 0.80, 0.70, 0.60, 0.50, 0.40, 0.30, 0.225,
0.15, 0.075, 0, −0.075, −0.15, −0.225, −0.30, −0.40, −0.50, −0.60, −0.70, −0.80, −0.95, −1.1, −1.4, −1.7,
−2.2, −2.7, −3.0, −3.3, −3.7, −4, −4.7, −5.5, −7, −12, −20, −50, −100, and 300 ppm.
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Table 5.3: Acquisition parameters of the 2D GRE sequence used for the standard in vivo CEST
protocol.
matrix size 128 x 116 pixel
field of view 196 x 174 mm2
slice thickness 5 mm
slice orientation transversal
phase encoding direction anterior - posterior
acquisition bandwidth 1220 Hzpix
k-space ordering centric out
RF pulse type fast
gradient mode fast
repetition time (TR) 3.7 ms
echo time (TE) 2.04 ms
5.10 Post-processing workflow
The post-processing workflow and data analysis had to be adapted due to the methodological
developments. For clarity, it is listed in the following:
1. Save the raw data files of the CEST, WASABI, and T1 sequences.
2. Reconstruct the images employing an adaptive combination algorithm (cf. Sec. 5.3). The
reconstruction incorporated a phase-unwrapping algorithm that resulted in a phasing of
~S0. The optimal set of coil weightings was calculated on the first acquired image and
applied to all offsets within one experiment. Thereby, the phase of the water signal was
kept constant for all frequency offsets ∆ω and Equation 4.4 holds.
3. Perform a fit on WASABI and T1 sequence to obtain the field maps and the T1 map.
4. Normalize the CEST data conventionally to obtain Z-spectra (Eq. 4.8).
5. Apply the novel normalization (cf. Sec. 4.2):
• Compute ~F0 in each voxel (Eq. 4.9). This can be achieved in two ways in order to
account for B0-inhomogeneities:
– Determine ~F0 = ~S(∆ωB0) with ∆ωB0 = 0 ppm utilizing a B0 map. The map
can be retrieved internally from a multi-pool fit of the conventional Z-spectrum
or from a WASABI measurement.
– Determine ~F0 = ~S(∆ωmin) at the frequency offset where the real part of the
acquired images around the direct water saturation (DS) is minimal:
∆ωmin = arg min
∆ω∈[−1,1]ppm
<
(
~S(∆ω)
)
(5.14)
• Perform the fat-corrected CEST normalization (Eq. 4.12).
• Calculate the fat fraction FF (Eq. 4.10). Knowledge of the FF supports data
interpretation and can be utilized for a semi-automated segmentation of the gland.
6. CEST evaluation (cf. Sec. 5.7):
• The signals of exchanging amide (and amine) protons fulfill assumption 3. CEST
signals are isolated by the multi-pool fit.
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• Calculation of the relaxation-compensated contrast, AREXamide, and correction for
B1-inhomogeneities.
Segmentation of the mammary gland
Breast morphology varies in each woman. Two approaches were followed to segment the gland
from adipose tissue:
1. Manual segmentation.
2. Semi-automated segmentation: First, the breast is pre-segmented manually from back-
ground and the pectoral muscle. Then, voxels exceeding a fat fraction of 40 % were
excluded. Furthermore, voxels in regions of high B1-inhomogeneities were excluded (i.e.
±40 %).
Regions of interests (ROI) were drawn manually or, in the contrast analysis of healthy women,
in an automated approach. Here, the thresholds for the above mentioned segmentation were
lowered to 30 % and ±30 %, respectively, and the mask dilated by 1 pix.
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The main results of this thesis are presented in the following chapter. First, the development
of robust field and T1 mapping of the human breast is shown. Then, the development of
the novel fat-corrected CEST normalization is demonstrated, enabling, for the first time,
relaxation-compensated amide contrast in the breast. Finally, the findings of three patient
examinations are presented.
6.1 Robust field and T1 mapping of the human breast at 7T
The goal of field mapping and determination of T1 is to perform relaxation compensation and
to correct for transmit field inhomogeneities. Therefore, fat saturation was chosen to suppress
lipid signals in the MR images. However, the built-in fat suppression of the GRE sequence
was insufficient due to high SAR and scan time. This led to the development of a new fat
suppression sequence, played out directly before image acquisition. Figure 6.1 compares a
fully relaxed in-phase image (|~S0|) with two fat-saturated ones acquired in the breast of a
healthy woman. Fat appears bright in GRE images, which prohibits an easy identification of
the mammary gland in the unsaturated case (Fig. 6.1A). Although fat tissue is sufficiently
suppressed by the built-in fat saturation, the image quality and sharpness is reduced by induced
stripe artifacts (Fig. 6.1B). These artifacts vanish if the developed fat saturation pulses are
played out prior to image acquisition (Fig. 6.1C). The mammary gland is easily recognizable.
This self-developed fat saturation outperforms the conventional technique and does not require
changes of imaging parameters.
A B
no fat saturation in-builtfat saturation 
self-developed 
fat saturation
C
Figure 6.1: Fully relaxed images acquired in the right breast of a healthy volunteer are shown. (A):
No fat saturation is applied. Due to the in-phase echo time and bright appearing fat signal, glandular
tissue is not easily identifiable. (B): The standard built-in fat saturation sufficiently suppresses fat
signal by the cost of an increased TR and SAR. Induced stripe artifacts reduce sharpness and image
quality. (C): The developed fat saturation is superior to the standard one. Glandular tissue is clearly
identifiable.
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The interplay of water and fat signals in MR images is highly dependent on imaging parame-
ters, especially the echo time (TE). Ideally, field mapping and T1 quantification should be
independent on both the phase relation of water and fat as well as the fat fraction (FF). In the
following, robust field mapping and T1 mapping with fat saturation is validated in vitro and
in vivo.
6.1.1 Field mapping with fat saturation
The WASABI sequence enabled simultaneous mapping of B0 and B1. The same GRE imaging
as the CEST measurements ensured comparability and avoided the need for registration.
In vitro verification
A phantom experiment with cream was perform to investigate the interplay of water and fat
after preparation in a WASABI sequence. Cream has a fat content of roughly 30 % and its
lipid resonances are comparable to human fat in the breast (cf. Figure 4.1).
The comparison of highly resolved WASABI spectra with and without fat saturation (see
Figure 6.2) demonstrates the necessity for fat saturation. The measurements were repeated for
various TE, covering one full cycle of water and fat. The spectra were averaged in regions of low
and nominal B1 (upper and lower row, respectively). Non-fat-saturated spectra (Fig. 6.2 A&C)
show a strong dependence on the chosen TE and do not appear symmetric, thus prohibiting a
reliable fit. High deviations are observable at ∆ω = 0 ppm as well as around ∆ω ≈ −3.5 ppm,
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Figure 6.2: Comparison of highly resolved WASABI spectra with and without fat saturation. The
spectra were obtained in cream (30 % fat content) with varying TE. Spectra were averaged in regions of
low (A&B) and nominal (C&D) B1 (cf. Fig. 6.3 A for ROI definition). The non-fat-saturated spectra
depend strongly on TE. WASABI spectra are symmetric and overlay, if the fat saturation pulses were
played out.
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Figure 6.3: Exemplary field maps obtained with fat saturation (TE = 1.91 ms, (A): relative B1 map,
(C): ∆B0-map). The fit results of relative B1 are shown in (B). As expected from the TE-dependence
of WASABI spectra (Fig. 6.2), the fit results depend on TE as well, if no fat saturation is applied. The
effect is less prominent for ∆B0 (D), as the symmetry axis of the WASABI spectra is less affected by
superposing oscillations. The observed ∆B0-drift is explainable by the long measurement time of the
whole experiment (several hours).
where the dominant methylene (CH2) peak resonates. For opposed-phase TE, Z-values above
1 occur. After fat saturation, all spectra overlay and no overlaying oscillations are observable
(Fig. 6.2 B&D), thus enabling a robust fit.
All spectra were fitted in order to compare the influence of the lipid induced deviations on
the field maps (Fig. 6.3). This smooth fat-saturated B1 map shows the ROI definition used
in the previous figure (Fig. 6.2). The outcomes for the relative B1 values are independent
of TE after fat saturation, but non fat saturated spectra result in B1-deviations of roughly
±5 %(Fig. 6.3 B). The difference in ∆B0 results obtained with and without fat saturation are
only noticeable in a region of higher B1. The position of the symmetry axis of WASABI spectra,
i.e. ∆B0, is less affected by superposing lipid signals. Additionally, a ∆B0-drift is observed in
Figure 6.3 D. It is explainable by the long measurement time of the whole experiment (several
hours) and an actual drift of the scanner frequency.
The developed fat saturation sufficiently suppresses lipid signals enabling robust field mapping
in vitro, despite B1-inhomogeneities and the high fat fraction. It is furthermore independent
on the phase of water and fat.
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Figure 6.4: Field maps obtained in the right breast of a healthy volunteer for the special cases of
in- and opposed-phase echo times (upper row: ∆B0, lower row: relative B1). Robust field mapping
of the whole breast is enabled, if the fat saturation is applied. High deviations are observable in the
non-fat saturated case (C&F). Due to the low fat content in the gland of the healthy volunteer, these
deviations are mainly observable outside the gland (G&H).
In vivo verification
In order to verify the applicability of a fat saturated WASABI sequence, the two special cases
of in- and opposed-phase TE were tested in a healthy volunteer with fat saturation applied.
Additionally, one measurement without fat saturation was performed for the opposed-phase
case. In order to match the breathing rhythm of the volunteer, the recovery time was ad-
justed to 5.6 s (see Sec. 5.9). This ensured sufficient synchronization of the sequence and
only minor movements were observable within the images. Fat saturated B1 and ∆B0 maps
closely resemble each other for both in- and opposed phase maps (Fig. 6.4 A&B and D&E,
respectively). The field maps can be obtained in the whole breast despite high fat fractions.
The non-fat-saturated maps show high deviations, mainly in fat dominant voxels, but yield
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comparable results in the center of the gland (Fig. 6.4 C&F). This result is explainable by
a look in the actual acquired spectra: Due to low fat content within the gland, spectra of
all three measurements overlay (Fig. 6.4 G). However, in fat dominant regions only the fat
saturated spectra overlay, while the unsaturated WASABI spectrum is strongly affected by
lipid signal (Fig. 6.4 H). These results verify the applicability of fat saturated field mapping in
the human breast by means of a WASABI sequence.
6.1.2 T1 mapping with fat saturation
This fat saturation method was programmed modularly and was therefore also combinable
with a saturation recovery sequence. Its suitability for robust T1 mapping in the human breast
is demonstrated in the following sections.
In vitro verification
The same cream-containing phantom was used to test the influence of TE on the measured
T1 relaxation times. T1 maps of homogeneous phantoms were acquired with and without
fat saturation (Fig. 6.5). The relaxation times in the four cream containing vials are equal,
despite the B1-inhomogeneities in the container (cf. Fig. 6.3 A). Furthermore, the obtained
T1 values are independent of TE (blue curve in Fig. 6.5 B). In contrast, T1 values obtained
without fat saturation depend strongly on TE (red curve). Deviations are maximal when lipid
signals oppose the water signal.
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Figure 6.5: Comparison of T1-mapping with and without fat saturation in cream. (A): The T1
map obtained with fat saturation in the phantom is homogeneous. (B): The observed relaxation time
depends strongly on the chosen TE, if no fat saturation is applied. The fat saturation enabled robust
T1 mapping despite B1-inhomogeneities and is independent of TE.
In vivo verification
Magnetization was measured at varying recovery times after complete signal saturation in a
saturation recovery experiment. Hence, the whole sequence is not rhythmical, prohibiting a
proper synchronization of the subjects’ breathing to the sequence. Image acquisition occurs
at different states of inhalation, causing a deformation and translation of the breast in the
images. As described in Section 5.6, a waiting time was introduced prior to complete signal
saturation. The introduction of a waiting time prolonged the acquisition time by a minute,
but reduced motion of the breast significantly. The T1 map was measured in one patient
with and without breathing synchronization and the gland’s centroid position was tracked
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Figure 6.6: T1 maps acquired with and without synchronization of the sequence to the breathing of
the examined patient (B and A, respectively). (C): The centroid of the gland was tracked for both
cases. The introduced waiting time prior to signal recovery minimized the movement of the breast
and ensured optimal T1 mapping. A shift of about 2 pixels for the non-synchronized case explains the
artifact in the edges of the T1 map (A).
(Fig. 6.6). A shift of almost 2 pixels (equals 3 mm, approximately 10 % of the segmented gland
diameter) was observed during the non-synchronized sequence. Consequently, an incorrect
determination of T1 occurred (Fig. 6.6 A). T1 values at the medial edges of the segmented gland
are underestimated while the lateral side of the gland appears overestimated. By adapting to
the patient’s breathing rhythm, almost no motion or deformation of the breast was observed
and the relaxation time was successfully determined in the whole segment (Fig. 6.6 B).
To investigate a possible influence of the chosen TE, the saturation recovery sequence with
fat saturation was tested in the breast of a healthy volunteer for the two special cases of an
in- and opposed-phase TE. The according T1 maps are displayed in Figure 6.7. Both maps
resemble each other closely. Averaged within the displayed segmented mammary gland, the
T1 values are T1, in−phase = (2.30± 0.25) s and T1, opp.−phase = (2.33± 0.30) s. T1 mapping of
the human breast is therefore independent of TE.
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Figure 6.7: T1 maps acquired in the
breast of a healthy volunteer. The im-
ages were acquired with fat saturation
at an in-phase and opposed-phase echo
time (A and B, respectively). The fat
saturation enables robust T1 mapping
in the human breast.
6.2 A novel normalization for CEST MRI to correct for fat-
signal-induced artifacts
CEST MRI in the human breast is affected by the fat content in the fibroglandular tissue.
Although the spectral region of amide proton resonances does not overlay with lipid resonances,
the fat signals lead to an incorrect normalization of Z-spectra and thus to inaccurate CEST
effects. A major part of this thesis was the development of a novel CEST normalization that
corrects for fat signal contribution in the post-processing without the need for fat saturation
schemes or water-fat separation. A comprehensive theory is given in chapter 4. The central
points of the methods are:
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• MR images detect a sum of the water and lipid signals (~S0 = ~W0 + ~F0). This leads to an
incorrect normalization in the conventional Z-spectrum:
Zconv(∆ω) =
|α(∆ω) · ~W0 + ~F (∆ω)|
| ~W0 + ~F0|
(6.1)
• The residual magnetization at ∆ω = 0 ppm represents the fully relaxed and collective
fat signal, enabling to define a fat-only image:
~F0 = ~S(0 ppm) (6.2)
• Images obtained at offsets ∆ω that do not coincide with lipid resonances can be corrected
for fat signal contribution and the novel CEST normalization can be performed:
Zcorr(∆ω) =
|~S(∆ω)− ~S(0 ppm)|
|~S0 − ~S(0 ppm)|
= |
~W (∆ω)|
| ~W0|
= α (6.3)
Its experimental verification is provided in the following section.
6.2.1 In vitro verification
To verify the functionality of the proposed fat-corrected normalization, a carnosine model
solution was prepared. Carnosine has a single exchanging amide proton resonating at around
∆ω = 3.2 ppm. A steadily increasing FF was created by filling oil on top of the solution
and placing the MR image slightly tilted at the interface. Five ROIs with increasing FF
were defined and used for the further analysis (Fig. 6.8). The area marked by the overlaying
white rectangle was used for the display of contrast maps shown in Figure 6.9. In this figure,
Z-spectra and amide contrast maps that were obtained by the conventional calculation as well
as by the novel method are compared (left and right column, respectively).
Figure 6.8: (A) MR image acquired in
the oil-carnosine phantom. The tilted
imaging plane created a fat fraction gra-
dient. The defined five ROIs provide a
steadily increasing fat fraction (B). The
white rectangle represents the region used
for illustration of contrast maps in Fig-
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The evaluation for the special case of an in-phase relation of water ~W0 and fat ~F0 is illustrated
in Figure 6.9 A-D. The amplitude of the amide resonance exhibits a strong FF dependence in
conventionally obtained Z-spectra (Fig. 6.9 A). The amide signal decreases with increasing
FF, while the residual magnetization at direct water saturation (DS, ∆ω = 0 ppm) increases.
This demonstrates that the amide signal is dependent on fat signal contribution, although
no lipids resonate in the spectral region of the APT. This dependency vanishes in Z-spectra
calculated by the novel normalization (Fig. 6.9 B). The amplitudes of the amide signal are
independent of the FF. Per definition (Eq. 6.3), Z-spectra overlay at DS. The pseudo rNOE
artifacts in the upfield spectrum at around ∆ω = −3.5 ppm can, however, not be corrected.
Here, partial lipid saturation changes the phase and amplitude of ~F (∆ω), which is a violation
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of Assumption 3 (see Sec. 4). The remaining differences of fat-corrected spectra can be
assigned to B1-inhomogeities within the imaging slice. The amide resonance was isolated by a
Lorentzian fit and compensated for relaxation and the AREXamide contrast was corrected for
B1-inhomogeneities. The contrast maps show a similar dependency on the FF (Fig. 6.9 C&D).
While the conventionally obtained AREXamide values decrease with increasing FF, the fat-
corrected AREXamide map appears homogenous.
For the second special case of an anti-parallel alignment of ~W0 and ~F0, the above described
artifacts are even more prominent (Fig. 6.9 E-H). Amide signal dependence of amide signal
on the FF is more pronounced, but increases with increasing FF. This effect is directly
reproduced in the contrast map. Uncorrected Z-spectra further exhibit phase artifacts around
∆ω = 0 ppm, where the residual magnetization flips and increases with FF. This is explainable
by the underestimated denominator in the opposed-phase case of the CEST normalization
(Eq. 6.1, [20, 63]). This underestimation also explains the pseudo rNOE artifact, which flips
to Z-values greater than 1. On the contrary, spectra at ∆ω = 0 ppm and around the amide
resonance overlay almost completely. The final AREXamide map is homogeneous (Fig. 6.9 H).
Again, pseudo rNOE artifacts cannot be corrected.
The fat-corrected AREXamide values are not exactly the same (Fig. 6.9 J). This is thought to
be caused by the long measurement time of several hours. However, the standard deviation
within the ROIs is significantly decreased and for all FF of the same order. The amide contrast
averaged within the ROIs based on conventional and corrected Z-spectra are listed in Table 6.1
and compared for the two above presented cases.
In order to prove the general applicability of the fat-correction approach for arbitrary phase
relations of ~W0 and ~F0 , the measurements have been repeated for various TE. Figure 6.9 I&J
shows the comparison of the amide contrasts obtained from conventionally (I) and fat-corrected
Z-spectra (J). The uncorrected AREXamide is dependent on both, TE and FF. The highest
deviations among the ROIs are observed for the opposed-phase case (i.e. TEopp.−phase =
2.55 ms), which was analyzed in detail above. In contrast to the conventional approach, the
developed fat-corrected normalization enables robust AREXamide quantification for up to 40 %
FF and arbitrary phases between the water ~W0 and the lipid signals ~F0.
Table 6.1: Comparison of mean AREXamide values in carnosine with and without fat correction
[10−2 Hz].
conventional fat-corrected
in-phase 3.51± 0.58 4.20± 0.08
opposed-phase 5.7± 1.6 4.50± 0.06
Figure 6.9: Z-spectra and amide contrast maps of the phantom experiment are compared for in-
and opposed-phase echo times (TE = 2.04 ms & 2.55 ms, respectively. B1 = 0.8 µT). Left column:
Conventional Z-spectra calculation (Eq. 4.8). The isolated amide signal and contrast decreased with
increasing fat fraction (FF) for the in-phase case (A,C), but increases with FF for ~W0 and ~F0 being
anti-parallel (E,G). After correction (right column, Eq. 4.12), the amide signal overlays in the Z-spectra
and as well as at ∆ω = 0 ppm (B,F). The amide signal is independent on FF. The fat-corrected
AREXamide maps are homogeneous (D,H). The experiment was repeated for various phase relations of
water and fat by varying TE (I): The contrast depends strongly on TE and FF when calculated on
conventionally obtained Z-spectra. After fat correction, the amide contrast is independent on both,
phase of ~W0 and ~F0 and the FF.
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Figure 6.9: In vitro verification of the novel fat-corrected CEST normalization. Description on the
previous page.
53
6 Results
6.2.2 In vivo verification
In order to validate the correction approach for APT-CEST MRI of the human breast, a
healthy volunteer was examined. Two complete CEST protocols were conducted subsequently
with an in- and opposed-phase TE.
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Figure 6.10: Magnitude of total (|~S0|, A,D), fat-only (| ~F0|, B,E) and water-only images (| ~W0|, C,F)
obtained in a breast of a healthy volunteer for the special cases of in- and opposed-phase TE (upper and
middle row, respectively). Although the two |~S0| images differ, the calculated fat and water-only images
resemble each other closely. Conventional Z-spectra (G, B1 = 0.6 µT) show the expected deviations in
the spectral region of the APT and the direct water saturation (ROI definition in B). The fat-corrected
Z-spectra (H) overlay in the spectral region of APT and the direct water saturation, thus verifying the
applicability of the novel CEST normalization for in vivo examinations.
The ~S0 images show the expected differences of intensities: fat tissue appears darker in the
opposed-phase case and regions of signal cancellation are observable (Fig. 6.10 A&D). As
expected from the carnosine experiment, conventional Z-spectra averaged within the displayed
ROI (Fig. 6.10 B) differ noticeably in the spectral region of the APT by an offset of the in-phase
Z-spectrum (Fig. 6.10 G). Again, the DS (∆ω = 0 ppm) and the pseudo rNOE artifacts show
the previously described TE dependent phase artifacts. Although the conventional Z-spectra
differ at ∆ω = 0 ppm, the fat-only images (| ~F0|) retrieved from the not-normalized image data
54
6.2 A novel normalization for CEST MRI to correct for fat-signal-induced artifacts
resemble each other closely (Fig. 6.10 B&E). The fat signal within the mammary gland is
comparatively low, which is in line with expectations for a young and healthy woman. The
calculated water-only images are very similar as well (Fig. 6.10 C&F). In addition, Z-spectra
calculated by the novel normalization overlay in the spectral region of the APT and the DS
(Fig. 6.10 H), demonstrating the general applicability of the method for in vivo examina-
tions. As seen in the phantom experiment, pseudo rNOE artifacts are still present in both cases.
In order to obtain isolated amide contrast maps, a five-pool Lorentzian fit was performed on
the in-phase data set. It was not, however, performed on opposed-phase spectra, as the phase
artifacts of the DS and the pseudo rNOE prohibit a reliable fit. Conventional and corrected
Z-spectra within a voxel in the gland are compared for two saturation powers (Fig. 6.11,
B1=0.6 µT & 0.9 µT). Z-values at ∆ω = 0 ppm do not drop to zero in both conventional
spectra, independent on the saturation power (Fig. 6.11 A&C), indicating a FF of about 8 %
within that particular voxel.
A clear amide signal as well as additional contributions from exchanging amine protons and
MT from semi-solid structures are identified by the fit. The CEST effects resonate with respect
to the water pool at around ∆ω = 3.5 ppm, ∆ω = 2.2 ppm, and ∆ω = −2 ppm, respectively.
The fifth pool was fitted to the pseudo rNOE artifact, but represents rather a simplification
to stabilize the overall fit (∆ω ≈ −3.5 ppm). A retrospective distinction between true rNOE
effects and lipid signal induced artifacts is not possible. After the fat correction is performed,
Z-spectra again go to zero (Fig. 6.11 B&D). The amide signal differs only slightly, which
is expected due to the low fat fraction in that voxel. The increased saturation power leads
and increased width and amplitude of the identified pools (B1 = 0.9 µT, cf. Fig. 6.11 C&D),
primarily the width of the water pool and the amplitude of MT. This is in line with the
expectations from the CEST theory (cf. Sec. 3.2).
A closer look at the DS reveals a B0-shift of the Z-spectra. As described in Section 5.7.2,
no direct B0-correction of spectra was performed within this work, as it would unnecessarily
smoothen the data. B0-inhomogeneities were however taken account for in each voxel by the
application of the inverse metric. For in vivo CEST data presented in this thesis, an internal
B0 map was calculated from the center frequency of the water pool. This was preferred to the
use of a B0 map from the WASABI sequence in order to avoid potential displacement between
CEST measurements and the WASABI due to subject movement.
The fat-corrected AREXamide maps were calculated for both saturation powers and displayed
in the mammary gland (Fig. 6.12 A&B). Contrast obtained at a saturation power of 0.9 µT is
increased compared to 0.6 µT and shows a correlation with B1-inhomogeneities (the relative
B1map of the examination is shown in Fig. 6.4). Ventral AREX values near the mammilla
are almost a two-fold increased from those of dorsal intensities. By interpolating between
the two displayed contrast by utilizing the relative B1 map, the contrast correction for B1-
inhomogeneities was performed (Fig. 6.12 C, see Sec. 5.7.4). This displayed contrast is
homogenous and does not correlate to the B1 map.
The impact of the developed fat correction becomes clear by comparing the final contrast
maps (i.e. after B1 correction), based on conventional and fat-corrected Z-spectra: The overall
contrast intensity is slightly lower in the conventionally calculated contrast (Fig. 6.12 D).
Contrast intensities decrease namely at the transition from glandular to adipose tissue, which
can be explained by the higher fat content in those regions. The differences in the inner gland,
with only little fat signal contribution, are competitively small.
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Figure 6.11: Conventional (A,C) and fat-corrected (B,D) Z-spectra are shown for two saturation
powers (upper row: B1 = 0.6 µT, lower row: B1 = 0.9 µT). The spectra show the results of an exemplary
voxel of an in-phase measurement (cf. Fig. 6.10, upper row). The results of the five-pool Lorentzian
fit analysis is superposed in solid colored lines. Conventionally obtained Z-spectra show a residual
magnetization of roughly 8 % due to fat signal contributions.
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Figure 6.12: Visualization of the B1-contrast correction in a healthy volunteer. The AREXamide maps
of different saturation powers ((A): B1 = 0.6µT, (B): B1 = 0.9 µT) were calculated on fat-corrected
Z-spectra (cf. Fig. 6.11). The contrast appears homogeneous after application of the B1 correction
(C), especially when compared to the conventionally obtained CEST contrast (D), where the contrast
decreases at the transition from glandular to adipose tissue.
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6.2.3 Further optimization of saturation parameters and reproducibility
The novel fat-correction was successfully verified for in vivo examinations. The further
optimization and test of reproducibility is described in the following.
Determination of the fat-only image ~F0
The core component of the novel CEST normalization is the post-processing based deter-
mination of a fat-only image ~F0 from CEST data itself, which enables the correction of the
acquired MR images. As described in Section 4, the ~F0 can be obtained in two ways: the fat
signal is either determined by a minimum approach in each voxel or by the utilization of a
B0 map. To investigate a possible influence on the the final contrasts, the data set presented in
figures 6.10&6.12 was completely evaluated for both methods. To compare the post-processing
itself, the B0 map was calculated internally (cf. Sec. 5.5). The according ~F0 images, i.e. |~F0,B0 |
and |~F0,min|, look almost identical (Fig. 6.13 A&B, respectively). However, in some voxels in-
tensity values of |~F0,min| are minimally lower (as expected, as it is a minimum based approach).
This is also displayed in a map of a relative deviation overlaid in the gland ( | ~F0,B0−~F0,min~F0,B0 |,
Fig. 6.13 C). However, a small region of higher relative deviations can be identified. An effect
on the final contrast, i.e. after fat and B1 correction, is hardly visible (Fig. 6.13 D&E). The
absolute difference shows no structure or any correlation to obtained maps or morphology
(Fig. 6.13 F). Only some randomly distributed voxels are different. However, with respect
to the mean intensity within the displayed segment, the overall contrast is about 2 % (i.e.
1 · 10−3 Hz) higher in the AREX map based on |~F0,B0 |. However, as this is within the detection
limit, both methods for the determination of ~F0 are equivalent. Within this thesis, all displayed
(other than in Fig. 6.13) and calculated contrast values are based on the minimum approach
and ~F0,min.
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Figure 6.13: Effect of the determination of ~F0 on the final contrast. The fat-only images obtained by
utilizing a B0 map and by a minimum approach are almost identical (A&B), but relative deviations are
observable (C). The final contrast maps generated by using ~F0,B0 and ~F0,min resemble each other (D&E,
respectively). The absolute difference between the two contrast reveals no correlation to obtained field
maps or morphology.
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Effect of saturation pulse length in Z-spectra
It is known that saturation parameters such as the pulse length tp influence Z-spectra and
the CEST contrast [28, 44]. To find optimal settings for APT-CEST in the human breast,
one healthy volunteer was examined with two different pulse lengths by keeping the DC
constant (15 and 100 ms, Fig. 6.14 A). The shorter pulses provide a higher saturation efficiency
and the Z-spectrum is minimally lower in regions of the APT, DS as well as at the pseudo
rNOE artifact. Furthermore, the width of the DS appears broader. As the whole correction
method depends on the residual magnetization at ∆ω = 0 ppm, the influence on the DS
was investigated in more detail in another examination of high spectral sampling for various
pulse lengths. Z-spectra of tp = 15 ms, 25 ms and 100 ms show differences in the saturation
profile (Fig. 6.14 B). Additional oscillations are superposed on the DS for shorter tp, leading
to deviations from an ideal Lorentzian line shape. Theoretically, optimal saturation transfer
is yielded for γB1tp ≈ 180°, which is fulfilled for the shorter pulses of tp = 15 ms, which can
explain an increased saturation efficiency. Furthermore, shorter pulses, are spectrally broader
and introduce a kind of saturation plateau (Fig. 6.14 B). It is worth mentioning that differences
in residual magnetization in the spectra can mainly be assigned to displacement/motion within
the sequences. The assumption of complete water saturation at DS (cf. Sec. 4, assumption 1 )
should be independent of tp and holds. The effects of pulse length on the amide contrast was
included in the following reproducability study.
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Figure 6.14: Effect of different saturation pulse lengths on Z-spectra. (A): The length of tp = 15 ms
shows a higher saturation efficiency than tp = 100 ms. (B): Highly sampled Z-spectra around 0 ppm
for varying pulse lengths tp. Shorter saturation pulses are superposed by additional oscillations, but
saturate with a broader spectral width.
Reproducibility study in a healthy woman
One healthy woman was repeatedly examined in order to test the reproducibility of the CEST
protocol. The saturation pulse length was set to 100 ms. In four of the six examinations,
the CEST sequences were repeated with tp = 15 ms (cf. previous paragraph). Although
the imaging plane was set intersect the mammilla as a reference point, repeated imaging of
the exact same slice was prohibited (Fig. 6.15 A). Hormonal-induced morphological changes
as well non-rigid deformations due to the positioning in the scanner caused the mammary
to gland appear different in each examination. However, the fat-corrected amide contrast
show reproducible values within the standard deviations. The four data points obtained with
smaller pulses yielded slightly increased contrast values. Therefore, the pulse length was set to
tp = 15 ms for all further measurements.
The observed T1 values agree within their standard variations, but a slight increase over the
course of measurements was observed (Fig. 6.15 C).
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Figure 6.15: Reproducibility study of the CEST protocol in a healthy volunteer. The same volunteer
was examined once a week for six times. Due to morphological changes of the breast as well as
non-rigid deformation, repeated imaging of the exact same slice was prohibited (A). Nevertheless, the
observed fat-corrected CEST contrast shows reproducible results (B). In four examinations, the CEST
measurement was repeated with tp = 15 ms. AREXamidevalues were slightly increased using the smaller
saturation pulse width. Observed T1-values increase minimally over the course of the examinations (C).
6.3 Dependence of amide contrast on menstrual cycle
Breast parenchym undergoes hormonal induced changes during menstrual cycle (cf. Sec. 5.9.1).
It is unknown whether periodic hormonal changes affect the amide CEST contrast, which could
be indicated by the blue curve in Figure 6.15 B. A clinical study was initiated to investigate
this question, for which the defined examination protocol is a result of the thus far presented
developments.
So far, three healthy volunteers were examined and the fat-corrected, relaxation-compensated
amide contrast obtained. Figure 6.16 A shows the amide contrasts averaged within the
mammary gland. Although this represents only a snapshot of the whole study, no correlation
of AREXamidewith the phase of the menstrual cycle (i.e. luteal and follicular phase) was found
yet. The data acquired in the reproducability study (cf. Fig. 6.15 B, red curve) was also
included. Contrast values agree within their standard variations. Thus, a reference value for
the amide contrast in healthy, premenopausal women was defined. The mean amide contrast
averaged over the ten data points over both hormonal phases is:
AREXamide, healthy = (3.74 ± 0.46) · 10−2Hz (6.4)
Also, no change in T1 between the two phases was detected in the three enrolled volunteers
(Fig. 6.16 B). However, relaxation times determined in V1 are smaller and appear to not to be
constant over the cycle.
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Figure 6.16: Dependence of the amide contrast on menstrual cycle (A). Three healthy women were
examined twice in different hormonal phases. Additionally, the data set shown in Figure 6.15 was
included. No clear correlation of CEST contrast with the examination day is observable. (B): Mean T1
values obtained in the small volunteer cohort.
6.4 Examinations of mamma carcinoma patients
For the first time, relaxation-compensated amide CEST was investigated in mamma carcinoma
patients. In the following, the results of three patients that were examined by the developed
CEST protocol within a clinical pilot study are presented.
Patient 1
In the first patient measurement no healthy tissue was present, as tumorous tissue covered
the whole gland within the imaging slice. This is also visible in the anatomical image (i.e.
T2-weighted, Fig. 6.17 D). The fat- and water-only images reveal that the tumor is embedded
in adipose tissue (Fig. 6.17 A-C). The FF in the tumor is about 8 %, as suggested by the
residual signal at DS in the conventional Z-spectrum (Fig. 6.17 E). Here, prominent CEST
signals of amide and amine protons are identified by the multi-pool fit. The amplitudes are
minimally increased by application of the fat-corrected normalization. Peak amplitudes are
higher compared to Z-spectra obtained in healthy women (cf. Fig.6.11). As expected, the
fat-corrected amide contrast is increased as well (Fig. 6.17 G&H). Averaged over the displayed
gland, the final contrast is AREXamide = (8.8 ± 2.4) · 10−2Hz. An intra-subject comparison
to healthy tissue is not possible. However, compared to the mean value obtained in healthy
women, AREXamide is increased by a factor of 2.4.
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Figure 6.17: First application of relaxation-compensated amide CEST in a mamma carcinoma patient.
(A)-(C): Magnitude of total (|~S0|), fat-only (| ~F0|) and water-only images (| ~W0|), respectively. (D):
Anatomical, T2-weighted image. A fat fraction of 8 % in the tumor is seen in the conventional Z-spectrum
((E), B1 = 0.6 µT, voxel marked in (B)). F: corresponding fat-corrected Z-spectrum. Conventional
(G) and fat-corrected (H) AREXamide maps. Although a direct comparison is prohibited as the tumor
covered the entire gland, an increase by a factor of 2.4 compared to the group of young healthy women
was observed.
Patient 2
In the second patient examination, the tumor is clearly distinguishable from healthy glandular
tissue. The breast showed only little signal fat contribution (Fig. 6.18 A-D). This is also
visible in the conventional Z-spectrum that almost drops to 0 at DS (approximately 2 % fat
fraction within the tumor, Fig. 6.18 E)). Hence, the conventional and fat-corrected AREXamide
maps resemble each other closely, with only a minor increase of intensity in the corrected map
(Fig. 6.18 H&I). The healthy tissue is in the order of the mean AREXamide determined in
healthy women. Averaged within the two manually drawn ROIs, the obtained contrast values
are AREXamide,healthy = (2.8 ± 0.9) · 10−2Hz and AREXamide,tumor = (8.4 ± 0.9) · 10−2Hz
(blue and red ROI in Fig. 6.18 D, respectively). Within the examined breast, the observed
amide contrast is three-fold increased in the tumor and increased by a factor of 2.4 when
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compared to the group of healthy women. Furthermore, a prominent amine resonance was
identified in tumorous tissue. The amine amplitude in the healthy mammary gland was
comparable to the examinations in healthy women. Hence, the tumor is also clearly visible in
the relaxation-compensated AREXamine map (Fig. 6.18 J). Although easily identifiable in the
anatomical image, no contrast is seen in the T1 map of the examined breast (Fig. 6.18 D&F).
Unfortunately, due to SAR restrictions within the measurement, the reference voltage of the
scanner could not be further increased. This resulted in low relative B1 values within the
comparatively small breast (Fig. 6.18 G). However, the B1 contrast correction worked in the
region displayed in the CEST maps.
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Figure 6.18: Patient 2 with an invasive ductal carcinoma in the left breast, clearly distinguishable
from surrounding healthy tissue. Due to a low fat signal, the conventional Z-spectrum almost drops
to 0 at ∆ω = 0 ppm (E; exemplary voxel marked in fat-only image, B). Hence, conventional and
fat-corrected amide contrast are very alike (H&I). AREXamide values in the tumor are a three-fold
increased compared to the surrounding healthy tissue (red and blue ROI in D). Interestingly, relatively
strong signals of amine resonances were identified, leading to a clear distinction of the tumor in the
AREXamine map (J).
Patient 3
The mammary gland examined in the third patient showed varying fat content (Fig. 6.19 A-
C). Connective regions with fat fractions of about 20 to 30 % are present in the FF map
(Fig. 6.19 E). In the conventional amide map, an apparent structure of increased intensity
is present, although not as differentiated as in patient 2. The fat-corrected AREXamide map
however shows less heterogeneity (Fig. 6.19 G). The apparent contrast in the conventional
case was induced by fat-signal contribution.
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Based on the clinical report, the tumor is located in the lower left with respect to the imaged
slice. A distinctive segmentation solely based on the T2-weighted image (Fig. 6.19 D) is
not possible without further clinical MR images, diagnostics from mammography, and/or
support by a professional radiologist. Also, the final amide maps shows no distinctive structure,
prohibiting a safe contrast comparison of healthy and tumorous tissue. However, the overall
AREXamide is increased compared to healthy women, approximately by a factor of 2. This
examination demonstrates that the developed correction method might improve the specificity
of amide CEST in tissues with varying fat content, as the fat signal induced artifacts could be
misinterpreted otherwise.
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Figure 6.19: Varying fat signal contribution was present in the mammary gland of patient 3, leading
to increased fat fractions (E). The apparent structure of increased intensity in the conventional
AREXamide map (F) becomes less heterogeneous after fat correction is applied (G). A distinctive tumor
segmentation based on the TSE-image (D) is not possible without further clinical data. The overall
contrast is however increased compared to healthy tissue.
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7 | Discussion
CEST MRI is an emerging field with increasing interest for application in other organs than
the human brain. Application in the human breast appears especially promising, as it may
correlate to chemotherapy response [14, 64, 81, 82] or tumor histology [15, 65, 83]. However, no
studies have been performed in the human breast that have isolated CEST effects by correcting
for known biases, such as spillover, T1 relaxation, and inhomogeneities of the saturation profile.
Therefore, the aim of this thesis was to enable relaxation-compensated CEST MRI in the
human breast.
MR imaging of the mammary gland is affected by lipid signal contribution of adipose tissue,
consequently leading to an incorrect CEST normalization and misleading artifacts in the
Z-spectrum [20, 63]. In this work, a general description explaining the interplay of water and
lipid signals, hence the origin of fat-signal-induced artifacts in Z-spectra, is formulated. A novel
normalization was developed to allow the correction of fat signals in post-processing, hence the
isolation of amide CEST signals. The development of robust field and T1 mapping enabled
— for the first time — relaxation-compensated amide CEST imaging of the human breast to
be corrected for field inhomogeneities. An examination protocol was set up to investigate
fat-corrected amide CEST in a clinical context.
7.1 Breast imaging at 7T
The human breast is a deformable organ, which presents a challenge for MR acquisitions
at high fields. Three aspects were introduced to ensure a successful run of the examination
protocol:
First, examined women wore scrubs during the examinations. The fabric provided support
and prevented a free hanging of the breast into the "open bucket" breast coil array. This
increased the overall comfort for the women and significantly reduced motion and deformation.
Some studies utilized a mattress for this purpose [67] or benefited from a cup-like coil design [68].
Second, the unilateral imaging of only one breast improved two things: The B0-shimming
improved significantly when performed on a single mammary gland, leading to an increase
in SNR. Furthermore, the field of view was reduced and thus image acquisition shortened to
400 ms. This is especially advantageous for CEST MRI, as the initial magnetization (|~S(∆ω)|)
recovers to an imaging steady state during acquisition, hence diminishing the CEST contrast
for longer acquisition duration [84]. Unilateral breast imaging was also preferred in previous
CEST studies [64, 67, 68].
Third, synchronization of the sequence to the subject’s breathing cycle. Breathing-induced
chest motion presented the main obstacle. Repeated breath-holds were unacceptable, as
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the acquisition of about 200 images during the CEST protocol was too demanding. Here,
the solution was the synchronization of the sequences to the natural breathing rhythm,
which increased the overall measurement time to about 20 min. The duration of the overall
measurement protocol is still similar to recent CEST MRI examinations of the brain at 3 T
[85]. The breathing synchronization worked well and only minimal deformations of the breast
were observed. Spatial displacements between the sequences were also minor, in some cases in
the order of ≈ 1 pix. Next to imaging artifacts, the chest motion induces periodic changes of
B0 [86]. Fluctuations of up to ±60 Hz per breathing cycle were observed (i.e. ≈ 0.2 ppm at
B0=7 T). The synchronization ensured that these B0 changes did not affect the phase-sensitive
imaging and occurred only during the CEST preparation. Although this proceeding still
requires a cognitively demanding cooperation, it was perceived acceptably by patients and
healthy volunteers. In the future, a respiratory belt might be deployed in order to achieve an
even more robust synchronization that is independent of subject cooperation [87].
7.2 Field and T1 mapping with fat saturation
The TE-dependent interplay of water and fat signals effects MR images and thereby falsifies
quantitative measurements of T1 relaxation time as well as field mapping sequences. The
AREX contrast scales linearly with the longitudinal relaxation time of water and is thereby
directly affected by uncertainties in the determination of T1. Therefore, robust and generally
applicable T1 mapping was a prerequisite for the relaxation-compensation of the determined
CEST contrast. Equivalently, as CEST effects depend on the irradiation amplitude and are
thereby affected by inhomogeneities of B1, robust B1 mapping was required for the contrast
correction. To achieve this, a fat-saturation-based approach was chosen. However, the built-in
fat saturation of the GRE sequence itself was not applicable, as it prolonged the image
acquisition by one second, increased the SAR, and induced blurring. The self-developed fat
saturation block, consisting of five spoiled Gaussian-shaped 90° pulses, was played out directly
before the image acquisition. It outperformed the built-in fat saturation in image quality,
acquisition duration, and SAR. Due to the centric-reordered image acquisition, lipid signals
have to be already saturated before the first k-space line acquisition. Lipid saturation was
sufficiently ensured by the fat saturation block, although it mainly suppressed the dominant
methylene peak (∆ω = −3.4 ppm).
Robust and TE-independent T1 mapping was feasible for both in vitro and in vivo application.
With respect to in vivo application, the overall importance of breathing synchronization is
emphasized. Due to the arrhythmical succession of the saturation sequence, considerable
motion and deformation of breast tissue was observed prior to synchronization. The introduced
waiting time ensured the synchronization of the saturation recovering sequence to the breathing.
The WASABI sequence presented the best candidate for field mapping as it provides mapping
of both B0 and B1 and finds more and more application in the CEST field [85, 88, 89]. In
combination with the fat saturation, robust and TE-independent results were ensured. However,
effectively only the B1 map was used for calculations. The B0-corrected AREX calculation
utilized an internally calculated B0 map. This post-processing-based approach was preferred,
as it avoids a potential displacement between the CEST and the WASABI sequences. B0 maps
obtained in the human breast are heterogeneous and a small displacement might cause artifacts
in the CEST contrast [89]. Motion correction and image registration would circumvent this
displacement, but were not feasible for the single-slice approach applied in this thesis. On the
other hand, B1 maps appear smooth and are less affected by tissue composition than by the
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coil setup itself [19]. Thereby, a minimal displacement between the measurements was not as
impactful on the final CEST contrast.
The duration of the WASABI measurement was approximately 4 min. The sequence could be
replaced by shorter B1 mapping methods in the near future. A fat-saturated dual refocusing
echo acquisition mode (DREAM) sequence represents a good candidate [90] and would take
less than half a minute. Another approach was suggested by van Rijssel et al., in which B1 is
estimated by the use of a generic template for field-mapping of the human breast at 7 T[19].
Both methods would, however, require a 3D CEST imaging and image registrations.
7.3 Isolated amide CEST MRI of the human breast at 7T
CEST MRI in the presence of fat leads to an incorrect normalization, thus pseudo CEST effects
[20] (cf. Fig. 4.4). Zhang et al. showed that Z-spectra are dependent on the TE and FF and
explained fat-signal-induced artifacts in the MTRasym contrast metric [63]. Within this thesis, it
was demonstrated that amide signals in conventional Z-spectra are also affected by lipid signals
and incorrect normalization (cf. Sec. 6.2). Furthermore, the isolated AREXamide contrast is
dependent on the FF and TE. A framework was derived describing the interplay of water
and lipid signals for arbitrary TE, hence arbitrary phases of water and fat (cf. Chapter 4).
This framework allowed the definition of a novel CEST normalization that includes a fat-
signal correction. The collective fat signal can be retrieved at the DS in Z-spectra in the
post-processing. No additional measurements are needed for this approach. Lorentzian fitting
enables the isolation of amide signals, which can then be corrected for T1 relaxation and
B1-inhomogeneities by the obtained field maps.
A novel normalization correcting for fat-signal-induced artifacts
The key finding of this novel normalization is that a fat-only image, ~F0, can be retrieved from
the Z-spectra at the spectral position of the DS. ~F0, i.e. the collective sum of lipid signals
of all ten resonances1, facilitates the calculation of water-only images, ~W0. Other studies
of CEST MRI of the human breast have applied fat saturation [14, 64] or water excitation
[65, 67, 68] to reduce fat artifacts. Both these approaches eliminate the signal of the main
lipid peak originating from methylene groups (CH2, δω = −3.4 ppm). The lipid resonance
at δω = 0.6 ppm and other peaks closer to the water resonance might be wrongly attributed
as water signal. A potential impact on the amide contrast is conceivable. Zhang et al. was
the first to combine a 3pt-Dixon water-fat-separation with CEST MRI of the human breast
[15]. However, an asymmetry contrast metric (i.e. MTRasym) was applied. As explained
in Chapter 4, the partial saturation of lipids at ∆ω = −3.5 ppm leads to a misalignment of
~F0 and ~F (∆ω). Consequently, there is potential bias on the MTRasym contrast.
This proposed novel normalization presents a SAR- and time-efficient alternative to fat satu-
ration or water excitation schemes and does not require additional measurements (e.g. the
acquisition of several echoes). All information needed is already obtained in the conventionally
acquired Z-spectrum. Furthermore, the utilization of image-phase information provides general
applicability for arbitrary phases of water and fat signals. Therefore, this approach is robust
against field inhomogeneities.
This novel normalization is based on three assumptions (cf. Section 4.2): Assumption 1 is
complete water saturation at the spectral position of the DS. This is fulfilled by the long
1Ten lipid resonances were identified in 1H-spectroscopy of the human breast at 7 T [31].
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saturation of several seconds. Additionally, the relaxation of water is long compared to the
image acquisition (about 2.3 s vs. 0.4 s, respectively). Water signal recovery during the short
readout is thereby negligible and Assumption 1 holds.
Assumption 2 is no partial lipid saturation at ∆ω = 0 ppm. This is only justified due to the
low saturation power (B1 < 1.5 µT). If higher saturation amplitudes were chosen, partial
saturation of lipids resonating close to the water could occur. Furthermore, the spectral
width of the saturation pulses was small ( ≈ 0.2 ppm for tp = 15 ms at B0=7 T). A spectral
broadening of breathing-induced fluctuations of B0, which is up to ≈ 0.2 ppm per breathing
cycle, would still not lead to a partial saturation of the prominent peak resonating around
0.6 ppm, which makes up to 10 % of the complete fat signal2. The second assumption is
therefore also justified. However, caution is advised for the combination of high-power CEST
approaches and this fat-correction approach. Using these two assumptions, one can determine
the collective fat signal ~F0 by the residual magnetization at ∆ω = 0 ppm.
Assumption 3 is no partial lipid saturation in the evaluated spectral region of interest. This
is fulfilled for the downfield and, in particular, for amide and amine resonances. Yet, this
does not hold true for frequency offsets coinciding with lipid resonances. Under the third
assumption, one can correct images for fat-signal-contribution by subtracting ~F0. However,
pseudo rNOE artifacts cannot be corrected by this fat correction since Assumption 3 is violated.
This method can be applied for fat fractions of up to approximately 40 %. The main limiting
factor for higher FF is the reduction of SNR in fat-dominant voxels. Yet, this is no drawback:
the CEST contrast mechanism is solely dependent on the water signal, which supports the
exclusion of fat-dominant voxels from the analysis in the mammary gland.
Optimization and parameter choices
An in-phase TE was chosen for all quantitative examinations, although the general formulation
of the fat-corrected normalization allowed arbitrary TE. The multi-pool fit showed a better
performance with in-phase Z-spectra, particularly at the DS and the pseudo rNOE peaks.
Furthermore, the overall SNR increased due to the parallel alignment of water ~W0 and fat
~F0. It is worth mentioning that an in-phase TE already minimizes the lipid-induced artifacts
in the conventionally calculated AREXamide contrast (cf. Fig. 6.9). Application of the novel
CEST normalization is nevertheless advised due to a high inter-subject variability of the FF.
Moreover, the in-phase condition does not hold in the whole gland due to field inhomogeneities
(cf. Fig. 2.6), which are particularly increased in larger breasts with high amounts of fat. The
novel CEST normalization accounts for B0 inhomogeneities by a voxel-wise determination of
~F0and is robust for arbitrary phase relations of water and fat signals.
Shorter saturation pulses (tp = 15 ms) were preferred to longer ones (tp = 100 ms), since they
provided a higher saturation efficiency. Theoretically, optimal saturation transfer is yielded
with γB1tp ≈ 180° saturation pulses, which is fulfilled for the shorter pulses of tp = 15 ms at
the chosen B1 ≈ 0.8 µT, thus explaining the increased saturation efficiency. A train of shorter
and spectrally broader RF pulses is also advantageous as it overcomes effects of breathing-
induced B0-fluctuations [67]. However, the 15 ms pulses introduce a kind of saturation plateau
(see Fig. 6.14 B). In the future, the multi-pool fit could be adapted to account for this by
introducing a constant plateau into the Lorentzian line of the water [85, 91]. This will, however,
2The amplitude of the downfield lipid peak makes up to 10 % of the overall lipid signal in highly resolved 1H
spectra of cream (cf. Fig. 4.1).
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have no or only a negligible effect on the reference Z-spectra in the spectral region of amide
resonances, nor is it considered to affect the fat correction itself.
The novel CEST normalization is based on the fat-only image ~F0, which is then subtracted
from all acquired images (cf. Eq. 4.12). ~F0 can be determined either by the utilization of
a B0 map or via a minimum approach. Both approaches yield comparable results and are
considered equivalent. However, in order to obtain the B0 map, an additional fit on conventional
Z-spectra is required. As mentioned above, a fit could be unstable if phase artifacts of the
DS or the pseudo rNOE artifacts are present, e.g. in the opposed-phase case or due to
high B0-inhomogeneities. The minimum approach is considered generally applicable and was
therefore chosen for all evaluations.
Relaxation-compensation
CEST MRI of the human breast benefits from the high field strength of 7 T by an increased
spectral resolution, despite the accompanying field inhomogeneities and associated challenges.
Due to the high spectral resolution, CEST effects were successfully isolated via a five-pool
Lorentzian fit. The AREX calculation requires a steady-state-like saturation, which was ensured
by the increased saturation duration due to breathing synchronization (tsat = 5.6 s ≈ 2.5 · T1).
Together, this enabled — for the first time — acquisition of a relaxation-compensated amide
contrast of the human breast. Moreover, a contrast correction for B1-inhomogeneities could
be performed. This is of special importance, as inhomogeneities of B1 are prevalent in breast
imaging.
7.4 Examinations of mamma carcinoma patients
Recent patient studies indicated the potential of CEST MRI as a diagnostic tool for mamma
carcinoma. Other studies have found a correlation of CEST contrast metrics to chemotherapy
response [14, 64] and to tumor histology [15, 65]. One goal of this thesis was to define
the examination and evaluation protocol for a clinical study of mamma carcinoma patients.
Prospectively, a small cohort will be evaluated by the end of the year (n=12). For the first
time, a correlation between histopathological features and the relaxation-compensated amide
contrast can be investigated (e.g. proliferation index Ki-67 or estrogen receptor ER). The
analysis of three patients was included in this work (cf. 6.4).
The first shown case presents the first amide contrast acquired in the human breast at 7 T to
be corrected for spillover, T1 relaxation, B1-inhomogeneities, and fat-signal contribution
(Fig. 6.17). This examination also proved the applicability of the whole examination protocol
as well as the novel fat correction. The multi-pool fit clearly identified amide and amine
resonances and the fat-corrected AREXamide contrast in the examined patient was significantly
higher than in healthy women by a factor of 2.4.
The second patient shown gives an example of a mammary gland with extremely low fat content
in both healthy and tumorous tissue (Fig. 6.18). This case demonstrates that the fat correction
method does not overcompensate in cases with a low FF. The tumor was clearly distinguishable
in the AREXamide map by a distinct border and, again, an increased contrast. Surrounding
healthy tissue showed contrast values in the order of the value obtained in young healthy women.
The clear differentiation of tumorous from healthy tissue in the contrast maps points out the
potential of CEST MRI as a non-invasive diagnostic tool. Interestingly, this case showed a
prominent amine resonance in the tumor, which was not as present in healthy women or other
patient examinations. Desmond et al. found that the amine resonance performed particularly
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well in the distinction of tumor necrosis and/or apoptosis from healthy tissue in mice that were
inoculated with a human breast cancer cell line [83]. Krikken et al. fit MT, water, and amide
signals to CEST MRI of breast cancer patients, but neglected amine resonances [14]. Ad-
ditional diagnostic utilizing of the amine resonance will hopefully be elucidated in future studies.
The third patient represents an exemplary examination of a mammary gland with varying
FF (Fig. 6.19). In this patient, significant fat-signal artifacts presented as increased contrast,
which could be mis-identified as a lesion or tumor. After the fat correction this contrast was
reduced, but the overall AREXamide increased. The visible structures in the amide map are
not clearly assignable to tumor or healthy tissue without the help of a radiologist and further
clinical data. Also, the T2-weighted image provides no clear distinction. Here, the increased
AREXamide might indicate tumor infiltration or progression. This patient examination demon-
strates the importance of the fat-signal correction. A high size variety of the mammary gland
as well as varying fat fractions within are expected for a larger patient and volunteer cohort.
The breast cancer patient examinations revealed an increased AREXamide contrast, despite
morphological and tumor-pathological variance. In a recent brain tumor study, an increased
amide contrast correlated to the overall survival of the patients [12]. Moreover, hyperintense
relaxation-compensated amide contrasts spatially correlated to regions of decreased ADC values
[12]. With respect to breast DWI, tumors appear in general hypointense in ADC maps, which
is explained by the increased cellularity of tumorous tissue [5]. The relaxation-compensated
amide contrast of the breast may potentially provide further clinical value, as it probes the
biochemical tumor environment.
In order to develop CEST MRI as a diagnostic tool for the human breast, three dimensional
imaging is required. This will allow the examination of the whole mammary gland rather than
just a single slice. The best candidate is the recently published spiral-centric-reordered 3D
GRE sequence (dubbed snapshot-CEST [84]). However, the acquisition time of this sequence
is prolonged compared to the current 2D approach (approx. 3 s compared to 0.4 ms). This
leads to a recovery of the magnetization during readout and subsequently, non-zero Z-values
at ∆ω = 0 ppm [84]. A direct application of the novel normalization is thereby prohibited. To
overcome recovery during readout, a variable-flip-angle approach could be implemented [92, 93].
3D imaging will also allow the registration of different measurements of a CEST examination.
Furthermore, registration to other clinical MR data can be performed. Non-rigid registration
procedures are challenging, especially in combination with varying image intensities. The
algorithm presented by Wech & Köstler, who used a low-rank approximation of Z-spectra to
correct the non-rigid motion of the thigh muscle [94], might applicable to the human breast.
7.5 Examinations of healthy volunteers
The human breast undergoes morphological and physiological changes during the menstrual
cycle. Hormonal-induced variations of the water content of the breast parenchyma as well as
the vascularity alter the perfusion properties and thereby affect dynamic contrast-enhanced
(DCE) MRI [41, 43, 95, 96]. The Guidelines from the European Society of Breast Imaging
therefore suggest a breast examination between the 5th and 12th day after the beginning of the
cycle [4]. Diffusion-weighted breast MRI provides information about cell density, but is not
found to be correlated with the menstrual cycle [5]. CEST MRI provides biochemical insights,
but whether or not hormonal variations lead to a change of CEST signals was hitherto not
investigated. Within this work, a potential correlation of hormonal changes with the isolated
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amide contrast was explored. So far, no change of AREXamide between has been observed
between the follicular and the luteal phase (i.e. shortly after the beginning of the cycle and
after ovaluation). This observation allowed the determination of a reference value of amide
contrast in healthy women (AREXamide, healthy = (3.74± 0.46) · 10−2Hz). A comparison with
CEST studies performed in the human breast is not appropriate, as this is the first application
of relaxation-compensation. In another study of relaxation-compensated CEST in the human
brain at 7 T, an average value for amide contrast in normal appearing white matter (nWM) is
given by AREXamide, nWM = (5.0± 0.4) · 10−2Hz 3[17]. The obtained AREXamide value in
the breast is in the same order of magnitude, but significantly lower than the reference value
of nWM. The tissue density of healthy breast parenchyma is not as high as human brain tissue.
Hence, the differences in amide contrast could be explained by a lower protein concentration.
The observed T1 relaxation times are close to the reported value of T1 = (2265± 65) ms [32].
No hormonal-induced change of T1 could be determined. This is in line with a previously
reported study in which an observed non-significant change of T1 was assigned to inter-
subject variability [43]. Both aspects, menstrual cycle dependency of the amide contrast
and T1 relaxation, are currently being investigated in a clinical pilot study. The data
presented here shows, rather, a snapshot (n=4), and any statistical significance is as of yet
inconclusive. However, the following can be assumed: hormonal-induced changes of the
relaxation-compensated amide contrast of healthy breast tissue are minimal and with regard
to tumor imaging, negligible.
3The value was read out from Fig. 5 f in Zaiss et al. [17].
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8 | Summary
Breast cancer is the most common cancer in women, and its early detection is associated
with better prognosis and mortality. The aim of this thesis was to provide a mammography
modality by means of relaxation-compensated amide CEST MRI. To achieve this, novel CEST
methods were successfully implemented and applied to examinations of healthy women and
mamma carcinoma patients.
To enable relaxation-compensated amide CEST MRI of the breast, a fat correction method
is required. For this purpose, a general theoretical description was derived explaining the
interplay of the water and fat signal in the CEST experiment and thus, the origin of artifacts
in Z-spectra. Phase information necessary for the fat correction was obtained by a newly
implemented rawdata-based analysis. It was demonstrated that the collective fat signal of
all lipid resonances can be retrieved by the Z-spectrum at the spectral position of the direct
water saturation. This allowed the definition of a novel CEST normalization that corrects
for fat-signal-induced artifacts in Z-spectra with a post-processing algorithm. This method
presents a SAR and time-efficient approach compared to other CEST MRI, as this method
does not require any further MR signal manipulation or additional measurements. The novel
CEST normalization was verified in vitro and its applicability was shown in vivo.
To apply the before mentioned methods in vivo, further problems had to be solved. First,
a profound interpretation of the amide signal in vivo requires the isolation from the back-
ground of multiple CEST signals. The isolation of CEST effects was achieved by adapting
the established Lorentzian five-pool fitting routines and applied them to fat-signal-corrected
and highly sampled Z-spectra. Second, the application of the inverse contrast metric yielded
isolation and compensation for T2 water relaxation. Finally, a fat saturation was developed
that outperformed the manufacturer-provided one, and enabled robust B1 field and T1 mapping.
The developed methods were finally incorporated in a sophisticated imaging protocol for
the examinations of patients. This enabled — for the first time — the examinations of
mamma carcinoma patients using relaxation-compensated amide CEST MRI. Breathing in-
duced non-rigid deformation of the breast could be largely avoided by a synchronization
of the MR sequences to the breathing of the examined women. In this work, the findings
of three patient examinations are presented. The observed AREXamide contrast was signifi-
cantly increased in the tumor with respect to healthy glandular tissue. The reference value
of AREXamide, healthy = (3.74± 0.46) · 10−2Hz was obtained as an average in four healthy
volunteers. No change of the amide CEST contrast was distinguishable in the two different
phases of the menstrual cycle.
With the methods established in this thesis, it is now possible to provide novel insights into
the biochemical environment of breast cancer. Furthermore, the developed methods could also
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potentially be applied to other fat containing entities, e.g. CEST imaging of the prostate or
kidney. The forthcoming studies in larger patient cohorts will evaluate improvements of the
specificity of the relaxation-compensated amide contrast and by this, the clinical impact of
the developed methods.
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Acquisition of proton spectra of fat-containing samples
In order to find suitable MR model solutions mimicking the in vivo fat composition, proton
spectra of various fat-containing substances were acquired at 14.1 T: lard, cream, sunflower oil
and egg yolk. They are displayed in Figure 4.1. Spectra were acquired on a ν0 = 600.13 MHz
spectrometer (AVANCE II NMR spectrometer, 14.1 T, Bruker, Karlsruhe-Rheinstetten, Ger-
many) using a 5 mm probe equipped with a z-axis gradient (Bruker, normal configuration
QNP 13C, 31P, 19F/1H probe). A complete FID was recorded after a short 90° pulse.
The in vivo proton spectrum was acquired at 7 T in the breast of a healthy volunteer (V3)
using a single-voxel semi-LASER sequence[97]. In comparison to the full LASER sequence
[98], two pairs of adiabatic refocusing pulses following a conventional slice selection ensured
the localization of the volume.
Start parameters of the multi pool fit
Table .1: Fit parameters 5-pool Lorentzian fit
Offset Water amides MT amines rNOE/fat
Zbase A Γ δ A Γ δ A Γ δ A Γ δ A Γ δ
lower boundary 0.5 0.02 0.3 −1.0 0 1 3.0 0 4.0 −4.0 0 0.75 1.7 0 0.75 −4.0
start value 1 0.9 1.4 0 0 1.4 3.5 0.1 50 −2.0 0 1 2.2 0 1 −3.5
upper boundary 1.0 1 10 1 0.1 2.0 4.0 1 90 0 0.15 2.0 2.7 0.4 3 −2.8
Table .2: Fit parameters Lorentzian and Carnosine
amides polynomial
A Γ δ a b c
lower boundary 0 0.25 3.0 −10 −10 0.8
start value 0.01 0.3 3.2 0 0 0.98
upper boundary 0.3 0.4 3.4 10 10 1.2
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Acquisition parameters cream phantom
Table .3: Acquisition parameters of the 2D GRE sequence used for field-mapping and T1 mapping in
cream. Coil: 1Tx/24Rx head coil. The WASABI and the T1 was repeated with varying TE twice, once
with and once without the developed fat saturation prior to imaging.
matrix size 128 x 128 pixel
field of view 128 x 128 mm2
slice thickness 5 mm
slice orientation transversal
repetition time (TR)[ms] 4.7 ms
echo time (TE)[ms] 1.91:0.1:2.81 ms
WASABI - settings
trecover 3 s
trecover, M0 15 s
sampling 201 offsets equally spaced between ∆ω = ±6 ppm
T1 - settings
recovery times trecover 16, 14, 12, 10, 9, 8, 7, 6.5, 6, 5.5, 5, 4.5, 4, 3.8, 3.7, 3.6, 3.5, 3.4, 3.3, 3.2, 3.1,
3, 2.9, 2.8, 2.7, 2.6, 2.4, 2.3, 2.2, 2.1, 2.0, 1.9, 1.8, 1.6, 1.4, 1.2, 1.0, 0.8, 0.6,
0.4, 0.25, and 0.1 s
Acquisition parameters carnosine phantom experiment
Table .4: Acquisition parameters of the 2D GRE sequence used for the carnosine-oil phantom. Coil:
1Tx/16Rx breast coil array. The CEST experiment was repeated for various echo times.
CEST - settings
number of pulses 95
pulse duration 100 ms
DS 95 %
Saturation amplitude B1 0.6 µT & 0.8 µT
sampling of ∆ω 300, 150, 75, 25, 8, 5.5, 5.0, 4.8, 4.6, 4.4, 4.25, 4.1, 4.0, 3.9, 3.8, 3.7, 3.6, 3.5,
3.4, 3.3, 3.2, 3.1, 3, 2.9, 2.75, 2.6, 2.45, 2.3, 2.15, 2, 1.85, 1.7, 1.55, 1.4, 1.25,
1.1, 0.95, 0.80, 0.70, 0.60, 0.50, 0.40, 0.30, 0.20, 0.10, 0, −0.10, −0.20, −0.30,
−0.40, −0.50, −0.60, −0.70, −0.80, −0.95, −1.1, −1.4, −1.7, −1.95, −2.2,
−2.4, −2.6, −2.8, −3.0, −3.2, −3.35, −3.5, −3.65, −3.8, −4.0, −4.3, −4.6,
−5, −5.5, −15, −75, −150, and −300 ppm
Imaging parameters
matrix size 128 x 128 pixel
field of view 141 x 141 mm2
slice thickness 3 mm
slice orientation coronal
repetition time (TR)[ms] 4.4 ms
echo time (TE)[ms] 1.9, 2.04 (in phase), 2.17, 2.43, 2.55 (opposed phase), 2.65
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Acquisition parameters of in vivo examinations
The standard examination protocol is provided in Chapter 5. If the examination protocol was
changed, it is provided here.
• Fig. 6.1:
– Volunteer: V1;
– FoV: 128x128
– Subfigures (A): TE: 3.7 ms; TR: 2.05 ms; (B): TE = 1.63 ms; TR = 17 ms; (C):
TE = 3.07; TR = 3.3 ms
• Figures 6.4, 6.7, 6.10, 6.11, 6.13:
– Volunteer V1;
– TEin-phase = 2.04 ms; TEopp-phase = 2.55 ms; TR = 4.2 ms
• Fig. 6.14 A & Fig. 6.15:
– Volunteer V1;
– tp = 15 ms &100 ms
• Fig. 6.14 B:
– Volunteer V2;
– tp = 15 ms, 25 ms & 100 ms;
– ∆ω = [−1.2 : 0.04 : 1.2] ppm;
– B1= 0.6 µT
• Fig. 6.19:
– Patient P3;
– The CEST-measurement at B1= 0.6 µT had to be repeated with a shorter offset
list (60 instead of 75, ∆ω = 295, 300, 290, 100, 50, 20, 12, 8, 6.25, 5.25, 4.7,
4.4, 4.25, 4.1, 3.95, 3.8, 3.7, 3.6, 3.5, 3.4, 3.3, 3.2, 3.1, 3, 2.9, 2.75, 2.6, 2.45,
2.3, 2.15, 2, 1.85, 1.7, 1.55, 1.4, 1.25, 1.1, 0.95, 0.80, 0.70, 0.60, 0.50, 0.40,
0.30, 0.225, 0.15, 0.075, 0, −0.075, −0.15, −0.225, −0.30, −0.40, −0.50, −0.60,
−0.70, −0.80, −0.95, −1.1, and −1.4 ppm).
– The multi-pool fit was adapted by discarding the fifth pool for rNOE/fat. Amide
resonances were robustly identified.
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